Search
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours.
We improved how this search looks for keywords. We also adjusted search filters. For details, see Website outages and upgrades. You can also download medicine data as published on this website in table format or check our search tips for help.
Filter by
Include documents
- (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) phosphorodiamidate [TH-302]
- (1aR,12bS)-8-cyclohexyl-N-(dimethylsulfamoyl)-11-methoxy-1a-(((1R,5S)-3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide hydrochloride (BMS-791325)
- (1R,2R)-2-[4-(5-methyl-1H-pyrazol-3-yl) benzoyl]-N-(4-oxo-6,7-dihydro-5H-pyrazolo [1,5-a]pyrazin-3-yl)cyclohexanecarboxamide (AZD5718)
- (1R,2R,3S,4S,5R,6S)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis (dihydrogen phosphate)
- (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy- 10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,- 14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]- oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyldimethyl-phosphinate (MK-8669, or AP23573)
- (1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide (ALXN2050)
- (1R, 4S, 5S, 6S)-4-[[(2s)-2-amino-4-(methylthio)-1-oxobutyl]amino]-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid,2,2-dioxide, monohydrate (LY2140023)
- (1S,3S)-3-({2-methyl-6-[1-methyl-5-({[methyl(propyl)carbamoyl]oxy}methyl)-1H-1,2,3-triazol-4-yl]pyridin-3-yl}oxy)cyclohexane-1-carboxylic acid (BMS-986278)
- (1S, 3S, 4R)-4-[(3aS, 4R, 5S,7aS)-4-(aminomethyl)-7a-methyl-1-methylidene-octahydro-1H-inden-5-yl]-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (acetic acid salt)
- (2-hydroxyethyl)trimethylammonium 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyloxy)-4- methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylate
- (2R)-2-amino-1-[3-( {2-[p-( 4-{3-[ (3,S-diamino-6-chloro-2-pyrazinyl)ca rbonyl ]guanidino }butyl )phenoxy ]ethyl}{ 3-[ ( 2R)-2-am ino-6-guanidinohexanoyla mino] propyl }amino )propylamino ]-6-guanidino-1-hexanone hexahydrochloride
- (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (MK-3102)
- (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-oxazolidin3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
- (2S) 4 [2 methoxyethyl [4 (5,6,7,8 tetrahydro 1,8 naphthyridin 2 yl)butyl] amino] 2 (quinazolin 4 ylamino)butanoic acid
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-{3-[(S)-(tetrahydrofuran-3-yl)oxy]-benzyl}-phenyl)-6-hydroxymethyltetrahydro-pyran-3,4,5-triol
- (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide (ACH-0144471)
- (3aR,4S,7aR)-octahydro-4-hydroxy-4-[(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester
- (3S,7S)-22-(3-(((2-((5-(2-Carboxyethyl)-2-hydroxybenzyl)(carboxymethyl)amino)ethyl)(carboxymethyl)amino)methyl)-4-hydroxyphenyl)-5,13,20-trioxo-4,6,12,19-tetraazadocosane-1,3,7-tricarboxylic acid (PSMA-11)
- (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)-carbonyl]-3-pyrrolidinone-O-methyloxime
- (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride
- (5aSa,17aRa)-20-Chloro-2-[(2S,5R)-2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-14,17-difluoro-6- (propan-2-yl)-11,12-dihydro-4H-1,18-(ethanediylidene)pyrido[4,3-e]pyrimido[1,6- g][1,4,7,9]benzodioxadiazacyclododecin-4-one (MK-1084)
- (6aR,10aR)-1-Hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H- benzo[c]chromene-9-carboxylic acid (lenabasum)
- (11beta,17beta)-17-hydroxy-11-[4-(methylsulfonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one
- (14S)-8-[3-(2-{dispiro[2.0.2^(4).1^(3)]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl- 2lambda^(6)-thia-3,9,11,18,23-penta-azatetracyclo[17.3.1.1^(11,14).0^(5,10)]tetracosa- 1(22),5,7,9,19(23),20-hexaene-2,2,4-trione calcium salt hydrate / tezacaftor / deutivacaftor (VX-121/ TEZ/D-IVA)
- (232 - 232’),(235 - 235’)-bis(disulfide) with immunoglobulin G4 anti-(human vascular endothelial growth factor A) (human-Mus musculus monoclonal OG1950 gamma-4-chain) disulfide with human-Mus musculus monoclonal OG1950 kappa-chain
- (E)-4-(2-(6-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine
- (E)-4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)oxy]-1-azoniatricyclo[3.3.1.13,7] decane 3,4-dicarboxy-3-hydroxybutanoate hydrate (ABT-126)
- (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one (SAR442168)
- (R)-2-[3-({Benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino}methyl)phenoxy]butanoic acid
- (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrilephosphate
- (R)-3-(1-cyclopropyl-3-(2-fluoro-4-(trifluoromethoxy)benzyl)ureido)piperidine-1-carboxamide (JNT-517)
- (R)-7-Chloro-benzo[b]thiophene-2-carboxylic acid (1-aza-bicyclo[2.2.2]oct-3-yl)-amide hydrochloride hydrate (EVP-6124)
- (R)-azasetron (besilate) (SENS-401)
- (R)-N-({5-[3-(2,5-Difluorophenyl)-2-(2,3-dihydro-1H-benzimidazol-2-ylidene)-3- oxopropanoyl]-2-fluorophenyl}sulfonyl)-2-hydroxypropanimidamide
- (RS)-Bacoflen
- (S)-1-{5-Phenyl-4-[(pyridin-2-ylmethyl)-amino]-thieno[2,3-d]pyrimidin-2-yl}-piperidine-3-carboxylic acid (2-hydroxy-ethyl)-amide
- (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran 3 yl) pyrimidine-5-carboxamide (PF-06865571)
- (S)-3-(OH)-desazadesferrithiocin-polyether, magnesium salt (FBS0701)
- (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide
- (S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride (KH176)
- (S)-lactic acid
- (S)-methoprene
- (S)-N-(1-amino-4-(dimethylamino)-1-oxobutan-2-yl)-5-(2,4-difluorophenoxy)-1-isobutyl-1H-indazole- 6-carboxamide
- (S)-Pyrrolidine-2-carboxylic acid compound with (2S,3R,4R,5S,6R)-2-(3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (2:1) ( LIK066)
- (Z)-N-(3-bromo-4- fluorophenyl)-N-hydroxy-4-(2-(sulfamoylamino)ethylamino)-1,2,5-oxadiazole-3-carboximidamide
- 1,4-dihydro-1-[(2R)-2-(2-methoxyphenyl)-2-[(tetrahydro-2H-pyran-4-yl)oxy]ethyl]-α,α,5-trimethyl-6-(2-oxazolyl)-2,4-dioxo-thieno[2,3-d]pyrimidine-3(2H)-acetic acid (GS-0976)
- 1-((S)-4-((R)-7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro- 2-(((S)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop- 2-en-1-one adipate
- 1-(2R,5R)-5-ethynyl-5-(hydroxymethyl)-2,5-dihydro-2-furanyl)-5-methyl-2,4(1H,3H)-pyrimidinedione (BMS-986001)
- 1-(4-(6-chloropyridazin-3-yl)piperazin-1-yl)-2-(4-cyclopropyl-3- fluorophenyl)ethan-1-one (BBP-671)
- 1-13C-caprylic acid
- 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol sodium salt
- 1-propanol
- 1-[ 4-bromo-5-[ 1-ethyl-7-( methylamino )-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl ]-2-fluorophenyl]-3-
- 1-{6-[(4M)-4-(5-Chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl}prop-2-en-1-one
- 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)-, monoethanesulfonate
- 1H-Isoindol-1-one,2-[[1-[2-(4-fluorophenyl)-2-oxoethyl]-4-piperidinyl]methyl]-2,3-dihydro-,hydrochloride, hydrate (1:1:2) (MIN-101)
- 2'-MOE antisense oligonucleotide targeting apoC-III (ISIS 678354)
- 2'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49d RNA (ATL1102)
- 2,6-Bis-{(1-napthalenyl-3,6-disulfonic acid)-oxyacetamido}-2,6-bis-2,6-bis-2,6-bis-(2,6-diamino-hexanoylamino)-2,6-diamino-hexanoic acid (diphenylmethyl)-amide, polysodium salt
- 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl) acetamide monohydrate
- 2-(2-(3-Butoxy-phenyl)-ethylamino)-N,N-dimethyl-acetamide hydrochloride
- 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)- 1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone monohydrate
- 2-(3-(1-carboxy-5-[(6-[18F]fluoropyridine-3-carbonyl)-amino]-pentyl)-ureido)-pentanedioic acid
- 2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]- 4-[(2- hydroxyethanesulfonyl)amino]benzamide hydrochloride
- 2-amino-5-(carbamylamino)pentanoic acid (L-citrulline)
- 2-Amino-N-(4-hydroxybicyclo[2.2.2]octan-1-yl)-5-(4-((1R,5S)-3- (tetrahydro-2H-pyran-4-yl)-3-azabicyclo[3.1.0]hexan-1- yl)phenyl)nicotinamide fumarate dihydrate (INCB-00928)
- 2-hydroxypropyl-ß-cyclodextrin (HP-ß-CD)
- 2-iminobiotin
- 2-propanol
- 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid tris(hydroxymethyl)aminomethane salt (1:1) (PF-06882961)
- 2-[3-(dimethyl-1H-1,2,3-triazol-5-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl]propan-2-ol
- 2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid
- 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile
- 2-[[8-chloro-3-[(4-chlorophenyl)methyl]-4-(difluoromethoxy)-2-ethyl-5-quinolinyl]oxy]acetic acid Llysine salt (GB001)
- 2-{(3S)-7-fluoro-4-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-yl}-N-methylacetamide (AZD9977)
- 2-{4-[4-(4-{5-[(1S)-1-amino-1-(4-fluorophenyl) ethyl]pyrimidin-2-yl}piperazin-1-yl)pyrrolo[2,1-f] [1,2,4]triazin-6-yl]-1H-pyrazol-1-yl}ethan-1-ol
- 2’-O-(2-methoxyethyl) modified antisense oligonucleotide targeting fused in sarcoma (FUS) pre-mRNA (ION363)
- 2’-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glial fibrillary acidic protein pre-mRNA (ION373)
- 3,3-Dimethyl-N-(6-methyl-5-{[2-(1-methyl-1H-pyrazol-4-yl)pyridine-4-yl]oxy}pyridine-2-yl)-2-oxopyrrolidine-1-carboxamide hydrochloride hydrate
- 3,4-dimethoxy-N-methylbenzohydroxamic
- 3,4-dimethoxy-N-methylbenzohydroxamic acid (Custodiol-N)
- 3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5-carboxamide
- 3,6-diamino-2,5-bis{N-[(1R)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrazine (MB-102)
- 3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5- fluorobenzonitrile
- 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile (TD-1473)
- 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole
- 3-(1H-indol-3-yl)-4-(2-(4-methyl-1-piperazinyl)-4-quinazolinyl)-1H-pyrrole-2,5-dione acetate(1:1)
- 3-(3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid
- 3-(4-acetamidophenyl)-2-(S)-methoxypropionic acid, or (S)-3-(4-acetamidophenyl)-2- methoxypropanoic acid (N-Acetyl-GED-0507-34-LEVO)
- 3-tert-butyl-N-{(1R)-1-[4-(6-{6-[4-({1-[4-(2,4-dioxo-1,3-diazinan-1-yl)phenyl]piperidin-4-yl}methyl)piperazin-1-yl]pyridin-3-yl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl]ethyl}-1,2,4-oxadiazole-5-carboxamide
- 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate
- 3-[4-(4-Aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl]-2-hydroxybenzonitrile (CRN00808)
- 3-[5-[(1R,2S)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1- yl]-N-[(3R)-tetrahydrofuran-3-yl]benzamide (AZD7594)
- 3-[[4-[(1S)-1-[4-(4-tert-butylphenyl)-3,5-dimethyl-phenoxy]-4,4,4-trifluorobutyl]benzoyl]amino]propanoic acid
- 3-[[5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl]methyl]-1-(2,2,2-trifluoroethyl)-1,3-dihydro-3-[[5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl]methyl]-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridine-2-one (JNJ-53718678)
- 4-0-(ß-D-galactopiranosyl)-D-xylopyranose
- 4-Amino-2-butoxy-8-[3-(pyrrolidin-1-ylmethyl)benzyl]-7,8-dihydropteridin-6(5H)-one (GS-9620)
- 4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3- cyclohexyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D arginine acetate
- 4-Hydroxy-n-(2-hydroxyethyl)-butyramide
- 4-[4-({4-[({2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-2,3-dihydro-1H-isoindol-4-yl}oxy)methyl]phenyl}methyl)piperazin-1-yl]-3-fluorobenzonitrile
- 4-[[9-[(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-transcyclohexanol (CC-930)
- 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide (JNJ-54781532-AAD)
- 5 fluorouracil
- 5 fluorouracil (topical application)
- 5%-Δ9-tetrahydrocannabinol standardised Cannabis extract
- 5, 7-dihydroxy-2-[3-hydroxy-4-methoxy-2-(2-methyl-2-propenyl) phenyl]-6, 8-bis (2-methyl-2-propenyl)-4H-chromen-4-one
- 5-(4,6-Dimethyl-1H-benzimidazol-2-yl)-4-methyl-N-[3-(1-methyl-4-piperidinyl)propyl]-2-pyrimidinamine 2,3-dihydroxybutanedioate hydrate (1:0.5:4) (JNJ-38518168)
- 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridi-2-yl)-4-methylbenzamide
- 5-(4-Fluoro-1-benzothiophen-2-yl)-8-methyl-1,9-dihydro-2H-[1,3]oxazolo[4,5-H][2,3]benzodiazepin-2-one (S44819)
- 5-aminolevulinic acid hydrochloride
- 5-{4-[(7-ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]-1-piperazinyl}-N-methyl-2-pyridinecarboxamide
- 5’-capped mRNA encoding HPV16 oncoprotein E6 and E7
- 6 fluoro-7-(2-fluoro-6-hydroxyphenyl)-(1M)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2- methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one
- 6,7-dihydro-5H-pyrrolo[1,2-c] imidazol-5-yl) - (benzo derivative)
- 6-mercaptopurine monohydrate
- 7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-[(3S)-tetrahydrofuran-3-yl]-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one maleate
- 9-valent human papillomavirus vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)
- 13 Grass Aqueous Extract
- 13-valent pneumococcal polysaccharide conjugate vaccine: pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F; diphtheria CRM197 conjugate
- 13C-urea
- 17 beta-estradiol
- 17-allylamino-17-demethoxygeldanamycin hydroquinone, hydrochloride
- 18-(p-[131I]-iodophenyl)octadecyl phosphocholine
- 177Lu-PSMA-617
- 224 Radium adsorbed in calcium carbonate microparticles
- 449-thioether with 1,1’-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl- 1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6-diazahexadec-1-yl]-44-(3-mercapto- 2,5-dioxo-1-pyrrolidinyl)-4,8,26,42-tetraoxo-2,13,16,19,22,29,32,35,38-nonaoxa-5,9,25,41- tetraazatetratetracont-1-yl]-2-[(2-bromo-2-methyl-1-oxopropoxy)methyl]-1,3-propanediyl] bis(2- bromo-2-methylpropanoate) core 9-arm star compd. with 4-hydroxy-N,N,N,10-tetramethyl-9-oxo- 3,5,8-trioxa-4-phosphaundec-10-en-1-aminium inner salt 4-oxide homopolymer (KSI-301)
- A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)
- A/California/7/2009 influenza-like virus strain
- A/Croatia/10136RV/2023 (H3N2)-like strain (A/Croatia/10136RV/2023, X-425A)
- A/Darwin/9/2021 (H3N2) - like strain (A/Norway/16606/2021, MEDI 355293) / A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020, MEDI 340505) / B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, MEDI 355292) / B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, MEDI 306444)
- A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)
- A/Victoria/4897/2022 (H1N1)pdm09 like strain (A/Victoria/4897/2022, IVR-238)
- A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) / A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022 IVR-237) / B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) / B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B) influenza virus
- A/VietNam/1194/2004
- A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167) / A/District of Columbia/27/2023 (H3N2)-like strain (A/Victoria/800/2024 CVR-289) / B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021)
- A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022, CVR-167) A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type) B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type)
- abacavir
- abacavir (as sulfate)
- abaloparatide
- abatacept
- abelacimab
- abemaciclib
- abetimus
- abicipar pegol
- abiraterone
- abiraterone acetate
- abrilumab
- abrocitinib
- acalabrutinib
- acalabrutinib maleate
- acamprosate
- acarbose
- acasunlimab
- acebutolol
- aceclofenac
- acellular tubular graft composed of human collagen types I and III and other extracellular matrix proteins, including fibronectin and vitronectin
- acemetacin
- acenocoumarol
- acetyl-cysteine
- acetyl-L-leucine ((s)-(acetylamino)-4-methylpentanoic acid) (IB1001)
- acetylcysteine
- acetylcysteine amide
- acetyl salicylic acid
- acetylsalicylic acid
- acetylsalicylic acid / bisoprolol
- aciclovir
- acipimox
- acitretin
- aclidinium
- aclidinium bromide
- acoltremon
- acoramidis
- acoramidis hydrochloride
- acotiamide
- acrivastine
- actinium-225-2-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-yl)-pentanedioic acid 3- iodo-D-Tyr-D-Phe-D-Lys-OH)-8-oyl-ε-(HO-Glu-ureido-Lys-OH)
- actinium chloride (non-carrier added)
- adagrasib
- adalimumab (14)
- adalimumab conjugated with (4S)-4-[2-(2-bromoacetamido)acetamido]-5-{3-[(4-{(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-4a,6a-dimethyl-2-oxo-6b-[(phosphonooxy)acetyl]-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8-yl}phenyl)methyl] anilino}-5-oxopentanoic acid; (ABBV-154)
- adapalene
- adavosertib
- adefovir dipivoxil
- adeno-associated viral vector serotype 8 containing the human glucose-6-phosphatase gene (DTX401)
- adeno-associated viral vector serotype 8 containing the human MTM1 gene (resamirigene bilparvovec)
- adeno-associated viral vector serotype 8 containing the human RPGR gene
- adeno-associated viral vector serotype 9 containing human sulfamidase gene
- adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene (LY3884963)
- Adeno-associated viral vector serotype rh.10 expressing beta-galactosidase (LYS-GM101)
- adeno-associated virus, serotype 9 (AAV9)-based non-replicating, self-complementary recombinant vector containing an expression cassette for the human ASPA transgene (scAAV9-CB6-hASPAopt)
- Adeno-associated virus serotype 2 encoding human aromatic L-amino acid decarboxylase
- adenosine
- adenovirus-mediated Herpes simplex virus-thymidine kinase gene
- adenovirus associated viral vector serotype 2 containing the human RPE65 gene
- adenovirus encoding vascular endothelial growth factor C
- adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
- adeno‐associated viral vector serotype 8 containing the 3' human otoferlin coding sequence / adeno‐associated viral vector serotype 8 containing the 5' human otoferlin coding sequence
- adjuvanted bluetongue virus vaccine
- adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5
- adjuvanted inactivated vaccine against avian influenza virus type A, subtype H7
- adjuvanted inactivated vaccine against Ornithobacterium rhinotracheale serotype A
- adjuvanted inactivated vaccine against porcine circovirus
- adjuvanted inactivated vaccine against porcine circovirus type 2
- adjuvanted inactivated vaccine against porcine circovirus type 2 in piglets
- adjuvanted inactivated vaccine for cattle against Staphylococcus aureus, coliforms and coagulase-negative staphylococci
- adjuvanted vaccine against classical swine fever
- adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
- adjuvanted vaccine against progressive atrophic rhinitis in piglets
- adjuvanted vaccine against tetanus
- adrenaline (epinephrine)
- adrenaline (tartrate)
- adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae)
- aducanumab
- adult differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B1) conjugated with the co-stimulatory regions 4-1BB and CD3z (ARI-0001
- afamelanotide
- afamitresgene autoleucel
- afatinib
- aficamten
- aflibercept (13)
- afoxolaner
- A fully humanized immunoglobulin G4 proline, alanine, alanine (IgG4 PAA) based bispecific antibody directed against cluster of differentiation 3 (CD3) receptor complex and G Protein Coupled Receptor Family C Group 5 Member D (GPRC5D) (JNJ-64407564)
- agalsidase alfa
- agalsidase beta
- agomelatine
- ajmaline
- alanine
- alatrofloxacin mesilate
- albaconazole
- albendazole
- albiglutide
- albumin interferon alfa-2b
- albutrepenonacog alfa
- aldafermin
- alder pollen
- aldesleukin
- alectinib
- alectinib hydrochloride
- alemtuzumab
- alendronate
- alendronate sodium trihydrate
- alendronic acid
- alendronic acid (as sodium alendronate trihydrate)
- alendronic acid (as sodium trihydrate)
- alfacalcidol
- alfentanil
- alfuzosin
- alginic acid
- alglucosidase alfa
- alicaforsen
- alipogene tiparvovec
- alirocumab
- alisitol
- aliskiren
- aliskiren hemifumarate
- alisporivir
- alitretinoin
- alizapride
- ALK inhibitor (NVL-655)
- allantoin
- allergen extract of Phleum pratense pollen
- allergen extract of Secale cereale pollen
- allergen for therapy: betula verrucosa (sublingual use)
- allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)
- allergen for therapy: Phleum Pratense
- allogeneic, ex vivo expanded, umbilical cord blood-derived, haematopoietic CD34+progenitor cells (CF)
- allogeneic, non-expanded, umbilical cord blood-derived, haematopoietic mature myeloid and lymphoid cells (NF)
- allogeneic B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell
- allogeneic bone marrow derived mesenchymal stromal cells, ex-vivo expanded (MC0518)
- allogeneic cultured postnatal thymus-derived tissue
- allogeneic equine adipose-derived mesenchymal stem cells
- allogeneic ex vivo expanded umbilical cord blood cells
- allogeneic glioma tumor cell lysates (inactivated)
- allogeneic glioma tumor cells (inactivated)
- allogeneic haptenised and irradiated cell lysates derived from glioma
- allogeneic haptenised and irradiated cells derived from glioma
- allogeneic human neural stem cells genetically modified to express c-MycERTAM, a c-Myc and modified oestrogen receptor fusion protein (CTX0E03)
- allogeneic Mesenchymal Precursor Cells (rexlemestrocel-L)
- allogeneic skin-derived ABCB5-positive dermal mesenchymal stromal cells
- allogeneic skin-derived ATP-binding cassette, sub-family B, member 5 (ABCB5)-positive mesenchymal stem cells (allo-APZ2-EB)
- allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)
- allogeneic umbilical cord-derived CD34- cells, non-expanded
- allopregnanolone
- allopurinol
- almagate
- almitrine
- almotriptan
- alnuctamab
- alnus glutinosa
- alogliptin
- alogliptin benzoate
- alpelisib
- alpha-1 antitrypsin
- alpha-1 proteinase inhibitor
- alpha-1-antitrypsin
- alpha-ketoglutaric acid
- alpha-R-lipoic acid choline ester tosilate
- alpha1-proteinase inhibitor (human)
- alpha1-proteinase inhibitor (human)
- alpha Connexin C-terminal 1 peptide
- alpha tocotrienol quinone
- alprazolam
- alprostadil
- alrefimotide
- alteplase
- altizide
- altrenogest
- aluminium hydroxide
- aluminium hydroxide adsorbed
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extract of Phleum pratense pollen
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extracts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extracts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) and Secale cereale (Cultivated Rye) pollen (50/50)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of equal amounts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) (1/5) each
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of equal amounts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) and Secale cereale (cultivated rye) pollen (50/50)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of equal amounts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) and Secale cereale (Cultivated Rye) pollen (75/25)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of equal amounts of Phleum pratense pollen and Secale cereale (cultivated rye) pollen (50/50)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and poa pratensis pollen (grasses-mix) and birch, alder and hazel pollen (tree-mix) (50/50)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (grasses-mix) and birch pollen (50/50)
- aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of Phleum pratense pollen
- aluminium oxide hydrated
- alvelestat
- alverine
- amantadine
- amantadine (hydrochloride)
- ambrisentan
- ambrosia artemisii folia
- ambroxol
- amfepramome
- amfepramone
- amifampridine
- amifampridine phosphate
- amikacin
- amikacin sulfate
- amino acid combinations
- amino acids
- aminocaproic acid
- aminosalicylate sodium
- aminosalicylic acid
- amiodarone
- amisulpride
- amitraz
- amitriptyline
- amitriptyline hydrochloride
- amitriptylinoxide
- amivantamab
- amlodipine
- amlodipine (as amlodipine besilate)
- amlodipine besilate
- amlodipine camsylate
- amorolfine
- amoxicillin
- amoxicillin trihydrate
- amphotericin B
- ampicillin
- ampicillin trihydrate
- amprenavir
- amsacrine
- anacetrapib
- anagrelide
- anagrelide hydrochloride
- anakinra
- anamorelin
- anamorelin hydrochloride
- anastrozole
- andecaliximab
- andexanet alfa
- androstanolone
- anecortave acetate
- angelica archangelica L., radix
- angiotensin II
- angiotensin II (LJPC-501)
- angiotensin II acetate
- anidulafungin
- anifrolumab
- aniracetam
- anitocabtagene autoleucel
- antazoline
- Anthoxanthum odoratum L.
- anthrax vaccine
- anti-(human vascular endothelial growth factor A) (human-Mus musculus monoclonal OG1950 gamma-4-chain)
- anti-alpha-synuclein human monoclonal antibody
- anti-alpha-synuclein recombinant humanised monoclonal antibody
- anti-alpha synuclein monoclonal antibody (BIIB054)
- anti-BAFF monoclonal antibody (LY2127399)
- anti-C1s Humanized IgG4 Monoclonal Antibody
- anti-C1s Humanized IgG4 Monoclonal Antibody (BIVV020)
- anti-CD3 mAb conjugated to ricin toxin A chain
- anti-CD7 mAb conjugated to ricin toxin A chain
- anti-CD40L humanized monoclonal antibody (SAR441344)
- anti-CD123 IgG1 humanised monoclonal antibody conjugated to N1-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-N6-((S)-1-(((S)-1-((3-((((S)-8-methoxy-6-oxo-11,12,12a,13-tetrahydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)-5-((((S)-8-methoxy-6-oxo-12a,13-dihydro-6Hbenzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)adipamide
- anti-human LAG-3 monoclonal antibody, human IgG4 isotype
- anti-IL-7Rα monoclonal antibody (S95011/ OSE-127)
- anti-IL-17A/F nanobody (MK 1095)
- anti-IL-21 humanized immunoglobulin G1-kappa monoclonal antibody (BOS161721)
- anti-melanoma mab fragments
- anti-mucosal addressin cell adhesion molecule antibody (SHP647)
- anti-neonatal Fc receptor human monoclonal antibody
- anti-neonatal Fe receptor human monoclonal antibody {M281)
- anti-PD1 humanized monoclonal antibody of the IgG4/kappa class (MK-3475) (pembrolizumab)
- anti-sclerostin human monoclonal antibody (AMG785)
- anti-TGFbeta fully human monoclonal antibody (NIS793)
- anti-T lymphocyte immunoglobulin for human use, horse
- anti-t lymphocyte immunoglobulin for human use, rabbit
- anti-VEGF and anti-DLL4 dual variable domain immunoglobulin (ABT-165)
- antigen of pre-pandemic strain A/Vietnam/1203/2004 propagated in Vero cells
- anti proprotein convertase subtilisin kexin type 9 humanized monoclonal antibody (PF-04950615)
- antisense oligonucleotide (30-mer) with nucleotide sequence 5′-GTAATTGCGGCAAGAAGAATTGTTTCTGTC-3′(CODA001)
- antithrombin alfa
- antithrombin iii
- AP214 Acetate (Αcetyl-(Lys)6-α-MSH, acetate salt)
- apalutamide
- Apis mellifera (801)
- Apis mellifera venom
- apitegromab
- apixaban
- Apolipoprotein A-1
- apomorphine
- apomorphine hydrochloride
- apraglutide
- apramycin sulfate
- apremilast
- aprepitant
- aprocitentan
- aprotinin
- aqueous allergen extract of birch
- aqueous allergen extract of pollen from Phleum pratense
- aqueous extract of grass pollen from Dactylis glomerata, Festuca pratensis, Holcus lanatus, Lolium perenne, Phleum pratense and Poa pratensis
- arachis hypogaea extract
- arcitumomab
- arfolitixorin
- argatroban
- arginine
- argipressin
- argon
- arimoclomol
- arimoclomol citrate
- aripiprazole
- aripiprazole monohydrate
- arpraziquantel
- arsenic trioxide
- arsenous anhydride
- artemether
- artenimol
- artesunate
- articaine (hydrochloride)
- arzoxifene
- asciminib
- asciminib hydrochloride
- ascorbic acid
- A self-complementary adeno-associated virus [AAV] serotype 8 virus particle encoding the human ornithine transcarbamylase [OTC] gene sequence (DTX301)
- asenapine
- asenapine maleate
- asfotase alfa
- asparaginase
- aspartic acid
- AstraZeneca Anti-SARS-CoV-2 monoclonal antibody (AZD3152)
- asunaprevir
- asundexian
- asunercept
- atacicept
- ataluren
- atazanavir
- atazanavir (as sulfate)
- atazanavir sulfate
- atenolol
- atezolizumab
- aticaprant
- atidarsagene autotemcel
- atinvicitinib
- atogepant
- atomoxetine
- atomoxetine (hydrochloride)
- atorvastatin
- atorvastatin (calcium trihydrate)
- atorvastatin (L-lysine salt)
- atorvastatin calcium
- atosiban
- atosiban (as acetate)
- atovaquone
- atracurium
- atrasentan
- atrasentan (hydrochloride)
- atropine
- atropine sulfate
- attenuated Chlamydophila felis (905 strain)
- attenuated feline panleucopenia virus (PLI IV)
- attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)
- attenuated live rabies vaccine virus, strain SPBN GASGAS
- aumolertinib
- autologous bone marrow-derived cardiopoietic stem cells
- autologous bone marrow-derived mononuclear cell enriched white blood cells
- autologous cartilage-derived articular chondrocytes, in-vitro expanded
- autologous CD3+CD4+CD25+CD127-FoxP3+ polyclonal regulatory T cells ex vivo expanded
- autologous CD3-positive T cells transduced with a retroviral vector containing an anti-B cell maturation agent chimeric antigen receptor gene
- autologous CD4+ and CD8+ T cells genetically modified with a lentiviral vector encoding a B cell maturation antigen-specific chimeric antigen receptor (JCARH125)
- autologous CD4+ and CD8+ T cells transduced with lentiviral vector encoding a chimeric antigen receptor (CAR) directed against CD19 and preserving the T cell phenotype of the leukapheresis starting material (YTB323)
- autologous CD4+ and CD8+ T cells transduced with lentiviral vector encoding a chimeric antigen receptor (CAR) directed against human B cell maturation antigen (BCMA) and preserving the T cell phenotype of the leukapheresis starting material (PHE885)
- autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene
- autologous CD34+ cells encoding ARSA gene
- autologous CD34+ cells transduced ex-vivo with retroviral vector (GIADAl) containing human adenosine deaminase gene from cDNA
- autologous CD34+ cells transduced with lentiviral vector containing the human Wiskott Aldrich Syndrom Protein gene
- autologous CD34+ cells transduced with lentiviral vector encoding the human beta-globin gene
- autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence
- autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence
- autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells
- autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding for the human Beta 2 Integrin/CD18 gene
- autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein
- autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human βA-T87Q-globin gene
- autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) genetically modified with the lentiviral vector IDUA LV, encoding for the human α-L-iduronidase (IDUA) gene (OTL-203)
- autologous CD34+ hematopoietic stem cells transduced ex vivo with EFS lentiviral vector encoding for the human adenosine deaminase gene
- autologous CD34+ hematopoietic stem cells with a CRISPR-edited erythroid enhancer region of the BCL11A gene
- autologous cultured chondrocytes
- autologous dendritic cells activated by transient exposure to killed prostate cancer cells ex vivo
- autologous dendritic cells pulsed with allogeneic tumour cell lysate
- autologous glioma tumor cell lysates (inactivated)
- autologous glioma tumor cells (inactivated)
- autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ATP-binding cassette, sub-family D (ALD), member 1 (ABCD1) from cDNA
- autologous haptenised and irradiated cell lysates derived from glioma
- autologous haptenised and irradiated cells derived from glioma
- autologous human chondrocytes in vitro expanded
- autologous human T cells genetically modified ex-vivo with a lentiviral vector encoding a chimeric antigen receptor (CAR) for B-cell maturation antigen (BCMA) (JNJ-68284528)
- autologous oral mucosal epithelial cells
- autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-T)
- autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor
- autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel)
- autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti CD19 CD28/CD3-zeta chimeric antigen receptor and cultured (KTE-X19)
- autologous selected renal cells
- autologous T-cells expressing a chimeric antigenic receptor against G protein coupled receptor class C, group 5, member D (GPRC5D) (BMS-986393)
- autologous T-cells from a melanoma metastasis (TM001)
- autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor (axicabtagene ciloleucel)
- autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains (CT053)
- autologous tumour-derived immunoglobulin idiotype coupled to keyhole limpet hemocyanin
- autologous tumour-infiltrating lymphocytes (LN-144/LN-145)
- autologous tumour-infiltrating lymphocytes (TILs) isolated from a patient's cancer tissue and expanded ex vivo (ITIL-168)
- AV2-cVLP-RBD SARS-CoV-2 (ABNCoV2)
- avacincaptad pegol
- avacopan
- avadomide
- avalglucosidase alfa
- avanafil
- avapritinib
- avatrombopag
- avatrombopag maleate
- avelumab
- avexitide acetate
- avian infectious bronchitis
- avian infectious bronchitis virus
- avian infectious bronchitis virus strain D388
- avian infectious bursal disease
- avian infectious bursal disease vaccine (live)
- avian infectious laryngotracheitis
- avian infectious laryngotracheitis and Marek’s disease vaccine (live)
- Avian influenza vaccine
- avian influenza vaccine (live recombinant)
- Avian influenza virus, subtype H5, haemagglutinin (recombinant)
- avian metapneumovirus
- avian reovirus
- avian reovirus, strain 11-12523, inactivated
- avian reovirus, strain S1133, inactivated
- avian reovirus and egg drop syndrome virus vaccine (inactivated)
- avian reovirus vaccine (inactivated)
- avibactam
- avibactam (AVI)
- avibactam sodium
- aviptadil
- avizafone (hydrochloride)
- avotermin
- axicabtagene ciloleucel
- axitinib
- azacitidine
- azagly-nafarelin
- azaperone
- azathioprine
- AZD8233 sodium, PCSK9-targeted, antisense oligonucleotide (ASO)
- azelastine
- azelastine (hydrochloride)
- azilsartan
- azilsartan medoxomil
- azithromycin
- azithromycin (monohydrate)
- azithromycin (ocular use formulations)
- azithromycin dihydrate
- aztreonam
- aztreonam (ATM)
- aztreonam lysine
- B/Austria/1359417/2021 like strain (B/Austria/1359417/2021, BVR-26)
- babesia canis, inactivated
- babesia rossi, inactivated
- bacillus calmette-guérin (BCG)
- bacillus clausii multi-antibioresistant spores
- baclofen
- bacterial DNA plasmid containing LACK gene from Leishmania infantum
- bacterial lysate of haemophilus influenzae
- balaglitazone
- balixafortide
- balovaptan
- Baloxavir marboxil
- baloxavir marboxil
- balsalazide
- bambuterol
- bamlanivimab
- Bardoxolone methyl
- bardoxolone methyl
- Baricitinib
- baricitinib
- barium selenate
- barnidipine
- basiliximab
- basmisanil
- batiraxcept
- batoclimab
- baxdrostat
- bazedoxifene
- B cell maturation antigen antibody-drug conjugate comprised of an immunoglobulin G1 humanized antibody conjugated covalently to the dibenzocyclooctyne noncleavable linker maytansinoid warhead (BMS-986352)
- becaplermin
- beclometasone
- beclometasone dipropionate
- beclomethasone dipropionate
- bedaquiline
- bedaquiline fumarate
- bedinvetmab
- begelomab
- belantamab mafodotin
- belatacept
- belimumab
- belrestotug
- Belumosudil
- belumosudil
- Belumosudil mesilate
- belzutifan
- bemarituzumab
- bemiparin
- bemnifosbuvir
- bempedoic acid
- bempedoic acid (ETC-1002)
- bempegaldesleukin
- benazepril
- benazepril hydrochloride
- bendamustine
- bendamustine hydrochloride
- bendroflumethiazide
- benfluorex
- benperidol
- Benralizumab
- benralizumab
- benserazide
- bentracimab
- benzalkonium chloride
- Benzamide, 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl] propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl] sulfonyl] (ABT-263)
- benzathine benzylpenicillin
- benzocaine
- benzoyl peroxide
- Benzo[b]thiophene-3-carbonitrile, 2-amino-4-[(4aS)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1H,12H-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-, (4R)- (LY3537982)
- benzydamine
- benzydamine (hydrochloride)
- Benzylamine derivative of benzofuran (BCX9930)
- benzyl nicotinate
- benzylpenicillin
- benzylpenicilloyl octa- L-lysine
- bepirovirsen
- beractant
- Beremagene geperpavec
- beremagene geperpavec
- Berotralstat
- berotralstat
- berotralstat dihydrochloride
- besilesomab
- beta-alanine
- betadex clathrate
- betahistine
- betahistine dihydrochloride
- betaine
- Betaine anhydrous
- betaine anhydrous
- betamethasone
- betamethasone acetate
- betamethasone dipropionate clotrimazole
- betamethasone valerate
- betaxolol
- bethanechol
- betibeglogene autotemcel
- Betrixaban
- betrixaban
- betrixaban maleate
- Betula alba
- Betulae cortex
- Betula pendula
- Betula verrucosa
- bevacizumab (12)
- bexagliflozin
- bexarotene
- bexicaserin
- bezafibrate
- Bezlotoxumab
- bezlotoxumab
- bezuclastinib
- bibrocathol
- bicalutamide
- biclotymol
- bictegravir
- bifikafusp alfa
- bilastine
- bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts
- bimatoprost
- bimekizumab
- binimetinib
- bintrafusp alfa
- biotin
- biperiden
- birch, hazel and alder allergen extracts
- birch bark
- birch bark extract
- birch pollen
- Birch pollen extract (Betula verrucosa)
- bis-choline tetrathiomolybdate
- bismuth (subcitrate)
- bismuth subcitrate potassium
- bisoctrizole
- bisoprolol
- bisoprolol (fumarate)
- Bisoprolol fumarate
- bisoprolol fumarate
- Bispecific T-cell engager antibody with a single-chain fragment crystallizable moiety that binds to B cell maturation antigen surface receptor on tumour cells and the cluster of differentiation 3 receptor on Tcells
- bitopertin
- bituminosulphonate (sodium)
- Bivalent anti-human myostatin adnectin recombinant human IgG1-Fc fusion protein (RO7239361)
- bivalent human papillomavirus vaccine (types 16, 18)
- Bivalirudin
- bivalirudin
- bivalrudin
- bleomycin
- blinatumomab
- BLU-667
- bluetongue-virus serotype-1 antigen
- bluetongue-virus serotype-2 antigen
- bluetongue-virus serotype-4 antigen
- bluetongue virus, serotype 3, BTV-3/NET2023, inactivated
- bluetongue virus serotype 8
- bluetongue virus serotype 8 antigen
- bluetongue virus vaccine (inactivated)
- bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3)
- bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3)
- bluetongue virus vaccine (inactivated) serotype 8
- bluetongue virus vaccine, serotype 8 (inactivated)
- bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated]
- Boceprevir
- boceprevir
- Bordetella pertussis (inactivated)
- Bordetella pertussis antigen: Filamentous Haemagglutinin
- Bordetella pertussis antigen: Pertactin
- Bordetella pertussis antigen: Pertussis toxoid
- Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin)
- Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3
- Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin
- borrelia outer surface protein A (OspA) serotypes (ST1-6) lipidated, fusion protein vaccine
- bortezomib
- Bosentan
- bosentan
- bosentan (as monohydrate)
- bosentan monohydrate
- Bosutinib
- bosutinib
- bosutinib (as monohydrate)
- botaretigene sparoparvovec
- Botulinum Neurotoxin Type A
- botulinum neurotoxin type a (150 kd) free from complexing proteins
- Botulinum toxin, Type A
- botulinum toxin a
- botulinum toxin a (except for centrally authorised products)
- botulinum toxin a - haemagglutinin complex
- Botulinum toxin type A
- botulinum toxin type a
- botulinum toxin type B
- Botulinum toxin type E
- bovine aprotinin
- bovine aprotinin, calcium chloride
- bovine aprotinin, human fibrinogen
- Bovine concentrated lactoserum containing specific immunoglobulins G against E. coli F5 (K99) adhesin
- bovine coronavirus, strain CA25, live
- bovine Herpes virus type 1 (BHV-1), strain Difivac (IBR-Marker virus, gE-negative), modified live (attenuated) virus
- bovine herpesvirus type 1 (live) vaccine
- bovine lung phospholipid
- bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccine
- bovine parainfluenza virus 3, strain SF-4 Reisinger, inactivated
- bovine respiratory syncytial virus, strain LYM-56, live
- bovine respiratory syncytial virus vaccine (live)
- bovine viral diarrhoea vaccine (modified live)
- bovine viral diarrhoea virus 1, E2 recombinant protein
- bovine viral diarrhoea virus 2, E2 recombinant protein
- bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant)
- Brachyspira hyodysenteriae, strain AqDys057, inactivated
- branaplam
- brazikumab
- Brensocatib
- brensocatib
- Brensocatib monohydrate
- Brentuximab vedotin
- brentuximab vedotin
- brexpiprazole
- brexucabtagene autoleucel
- briakinumab
- brigatinib
- brigimadlin
- brimonidine
- brimonidine tartrate
- brincidofovir
- brinzolamide
- Brivaracetam
- brivaracetam
- brivudine
- broadly neutralizing anti-HIV human monoclonal antibody (VH3810109)
- brodalumab
- Brolucizumab
- brolucizumab
- bromazepam
- bromfenac
- bromfenac sodium sesquihydrate
- bromhexine
- bromocriptine
- bromocriptine (mesilate)
- bromperidol
- brotizolam
- Brucella abortus, strain AQ1302, protein extract
- Bruton’s tyrosine kinase inhibitor
- bucelipase alfa
- Budesonide
- budesonide
- budesonide, micronised
- bufexamac
- buflomedil
- bulevirtide
- bulevirtide acetate
- bumetanide
- buparlisib
- bupivacaine
- bupivacaine / epinephrine
- buprenorphine
- buprenorphine hydrochloride
- bupropion
- bupropion hydrochloride
- burosumab
- buserelin
- buspirone
- busulfan
- Butafosfan
- butafosfan
- butoconazole
- C1 inhibitor (human)
- cabazitaxel
- cabergoline
- cabotegavir sodium
- cabotegravir
- cabozantinib
- cabozantinib (s)-malate
- cadazolid
- Caffeine
- caffeine
- Caffeine citrate
- caffeine citrate
- cagrilintide
- calcifediol
- calcipotriol
- calcipotriol hydrate
- calcitonin
- calcitonin salmon
- calcitriol
- calcium
- calcium (citrate)
- Calcium, N,N'-1,2-ethanediylbis[N-[[3-(hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl]glycine] manganese complexes
- calcium carbonate
- calcium chloride
- calcium chloride (dihydrate)
- calcium chloride, aprotinin
- calcium chloride dihydrate
- calcium folinate
- calcium lactate gluconate
- calcium salts
- calcium valproate
- camellia sinensis
- camidanlumab tesirine
- camlipixant
- camphor
- camrelizumab
- canagliflozin
- Canakinumab
- canakinumab
- Canarypox virus, strain vCP1338, expressing feline interleukin-2 gene, Live
- canarypox virus expressing feline leukemia virus, live
- Candesartan
- candesartan
- Candesartan cilexetil
- candesartan cilexetil
- cangrelor
- cangrelor (tetrasodium)
- canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant)
- canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus
- canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B, canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090, L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091...
- canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B and canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated)
- canine herpes vaccine (inactivated subunit)
- Canine herpesvirus (F205 strain) antigens
- canine leishmaniasis vaccine (recombinant protein)
- canine leptospirosis vaccine (inactivated)
- canine parainfluenza type-2 virus, strain CPiV-2 Bio 15 (live attenuated)
- Canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090 and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091 (all inactivated)
- canine parainfluenza virus
- canine parainfluenza virus, leptospira and rabies virus
- canine parainfluenza virus, leptospira and rabies virus.
- canine parainfluenza virus and Leptospira
- cannabidiol
- capecitabine
- capivasertib
- Caplacizumab
- caplacizumab
- Capmatinib
- capmatinib
- capmatinib dihydrochloride monohydrate
- capromorelin tartrate
- capsaicin
- capsici acris
- captopril
- carbachol
- carbamazepin
- carbamazepine
- carbetocin
- carbidopa
- carbidopa monohydrate
- carbocisteine
- carbomers
- carboplatin
- carboprost
- carfilzomib
- carglumic acid
- cariprazine
- cariprazine hydrochloride
- carisbamate
- carisoprodol
- carmustine
- carmustine (implant)
- carotuximab
- carprofen
- carrageenin
- carteolol
- carum carvi L., fructus
- carvedilol
- casirivimab
- casopitant
- caspofungin
- caspofungin (as acetate)
- caspofungin acetate
- catequentinib
- cathine (hydrochloride)
- catridecacog
- catumaxomab
- CD19-directed genetically modified autologous cell-based product consisting of purified CD4+ T cells (CD4+ cells)
- CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ T-cells (CD8+ cells)
- cebranopadol
- cedazuridine
- cediranib maleate
- cefadroxil
- cefalexin
- cefalexin sodium
- cefazolin
- cefepime
- cefepime dihydrochloride monohydrate
- cefiderocol
- cefiderocol sulfate tosilate
- cefodizime
- cefoperazone
- cefotaxime
- cefovecin
- cefovecin (as sodium salt)
- cefpodoxim
- cefpodoxime
- cefpodoxime proxetil
- cefprozil
- cefquinome
- ceftaroline fosamil
- ceftazidime
- ceftazidime pentahydrate
- ceftibuten
- ceftiofur
- ceftobiprole
- ceftobiprole medocaril
- ceftobiprole medocaril (sodium)
- ceftolozane
- ceftolozane sulfate
- ceftriaxone
- cefuroxime (as axetil)
- cefuroxime axetil
- cefuroxime sodium
- celecoxib
- celiprolol
- cell-associated live recombinant turkey herpesvirus (strain HVP360), expressing the fusion protein of ND virus and the VP2 protein of IBD virus
- cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus
- cell-associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT) expressing the fusion protein of newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus
- cell-free solution of lysed Escherichia coli culture, strain Laves
- cemdisiran
- cemiplimab
- cendakimab
- cenegermin
- cenerimod
- cenicriviroc
- cenobamate
- censavudine
- ceralasertib
- cereal pollen
- ceritinib
- cerivastatin
- cerliponase alfa
- certepetide
- certolizumab pegol
- certoparin
- cetirizine
- cetirizine pseudoephedrine
- cetrelimab
- cetrorelix
- cetrorelix (as acetate)
- cetrorelix acetate
- cetuximab
- cetylpyridine
- cevostamab
- ChAdOx1-SARS-COV-2
- characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
- chelidonium majus L., herba
- chemically modified extract of grass pollen from Holcus lanatus, Phleum pratense and Poa pratensis
- chemically modified human recombinant sulfamidase
- chenodeoxycholic acid
- Chikungunya vaccine (live)
- Chikungunya vaccine (recombinant, adsorbed)
- Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated
- Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
- Chikungunya Virus Virus-Like Particle Vaccine / aluminum hydroxide
- chimeric antibody to mesothelin (MORAB-009)
- chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4
- chimeric monoclonal anti-Shiga toxin antibodies cαStx1 and cαStx2
- chimeric murine-human anti Interleukin 6 monoclonal antibody
- chimeric yellow fever dengue virus serotype 1 (live, attenuated)
- chimeric yellow fever dengue virus serotype 2 (live, attenuated)
- chimeric yellow fever dengue virus serotype 3 (live, attenuated)
- chimeric yellow fever dengue virus serotype 4 (live, attenuated)
- Chimpanzee Adenovirus encoding the SARS CoV 2 Spike glycoprotein (ChAdOx1-S)
- chlordiazepoxide
- chlorhexidine
- chlorhexidine diacetate
- chlorhexidine digluconate
- chlorhexidine gluconate
- chlormadinone
- chlormadinone acetate
- chlormethine
- chlormezanone
- chlorocresol (4-chloro-3-methylphenol)
- chloroprocaine hydrochloride
- chloroquine
- chloroquine phosphate
- chlorphenamine
- chlorphenamine maleate
- chlorphenoxamine hydrochloride
- chlorpromazine
- chlorprothixene
- chlorquinaldol
- chlortalidone
- chlortetracycline hydrochloride
- cholecalciferol
- cholera vaccine (inactivated, oral)
- Cholera vaccine, live attenuated, oral (strain CVD 103-HgR)
- cholera vaccine, oral, live
- cholic acid
- choline alfoscerate
- chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
- chondroitin sulfate
- choriogonadotropin alfa
- ciclesonide
- ciclosporin
- cidofovir
- cilastatin
- cilastatin sodium
- cilazapril
- cilengitide
- cilgavimab
- cilgavimab (AZD1061)
- cilofexor
- cilostazol
- ciltacabtagene autoleucel
- cimicifuga racemosa (L.) nutt., rhizoma
- cimicoxib
- cinacalcet
- cinacalcet hydrochloride
- cinchocaine hydrochloride
- cineole
- cinolazepam
- cinoxacin
- Cipaglucosidase alfa
- cipaglucosidase alfa
- ciprofibrate
- ciprofloxacin
- ciprofloxacin hydrochloride
- ciraparantag
- cisapride
- cisatracurium
- cisplatin
- citalopram
- citral
- citric acid
- citric acid (as citric acid anhydrous)
- citrulline malate
- Cladribine
- cladribine
- clarithromycin
- clascoterone
- classical swine fever vaccine (live recombinant)
- Classical Swine Fever Virus (CSFV) -E2 subunit antigen
- clavulanate
- clavulanic acid
- clazakizumab
- clazosentan
- clebopride
- clenbuterol
- clesrovimab
- clevidipine
- clevidipine butyrate
- clindamycin
- clindamycin hydrochloride
- clindamycin phosphate
- clioquinol
- clobazam
- clobenzorex
- clobetasol
- clobetasol propionate
- clobutinol
- clodronic acid
- clofarabine
- clomipramine
- clomipramine hydrochloride
- clonazepam
- clonidine
- clonidine hydrochloride
- clopidogrel
- clopidogrel (as besilate)
- clopidogrel (as hydrobromide)
- clopidogrel (as hydrochloride)
- clopidogrel (as hydrogen sulfate)
- clopidogrel (bisulfate)
- clopidogrel besilate
- clopidogrel hydrochloride
- clopidogrel hydrogen sulfate
- clorsulon
- closantel
- clostridioides difficile
- Clostridioides difficile toxoid A
- Clostridioides difficile toxoid B
- Clostridium-perfringens-type-A alpha toxoid
- clostridium botulinum neurotoxin type A
- Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
- Clostridium botulinum toxin type A, purified neurotoxin
- Clostridium botulinum type A neurotoxin complex
- Clostridium collagenase
- Clostridium difficile toxin A human monoclonal antibody
- Clostridium difficile toxin B human monoclonal antibody
- Clostridium perfringens, type A, alpha toxoid
- clostridium perfringens type A/C toxoids
- Clostridium perfringens type C / Escherichia coli F4ab / E. coli F4ac / E. coli F5 / E. coli F6 / E. coli LT
- Clostridium perfringens vaccine (inactivated)
- clostridium perfringens vaccine, inactivated
- Clostridium tetani toxoid / Vcp 2242 virus / Vcp1529 virus / Vcp1533 virus / vCP3011 virus
- clotiazepam
- clotrimazole
- clozapine
- Cluster of differentiation 40 (CD40) ligand antagonist comprising two identical Tn3 modules fused to human serum albumin, with each Tn3 module being an engineered form of the third fibronectin type III protein domain of human Tenascin C (VIB4920)
- co-crystal of tramadol (hydrochloride)
- Coagulation Factor VIIa (Recombinant)
- cobicistat
- Cobimetinib
- cobimetinib
- cobimetinib hemifumarate
- cobolimab
- coccidiosis vaccine live for chickens
- Codeine
- codeine
- codeine camphosulphonate
- codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract
- colchicine
- colecalciferol
- colesevelam
- colesevelam (as hydrochloride)
- colesevelam hydrochloride
- colestilan
- Colistimethate sodium
- colistimethate sodium
- colistin
- colistin sulfate
- collagenase Clostridium histolyticum
- complement factor B antisense oligonucleotide (RO7434656)
- concentrate of proteolytic enzymes enriched in bromelain
- concentrate of proteolytic enzymes in bromelain
- concizumab
- Conestat alfa
- conestat alfa
- conjugated estrogens
- Copanlisib
- copanlisib
- copanlisib dihydrochloride
- copper (64Cu) chloride
- Copper (64Cu) oxodotreotide
- corifollitropin alfa
- corticorelin
- corticotropin
- corylus avellana
- cosibelimab
- cotadutide
- Covalently closed DNA plasmids coding for cytomegalovirus phosphoprotein 65 and glycoprotein B genes (ASP0113)
- COVID-19 mRNA vaccine
- COVID-19 sa-mRNA Vaccine
- COVID-19 vaccine (Ad26.COV2-S (recombinant))
- COVID-19 vaccine (Ad26.COV2-S [recombinant])
- COVID-19 Vaccine (ChAdOx1-S [recombinant])
- COVID-19 vaccine (ChAdOx1-S [recombinant]) (AZD1222)
- COVID-19 vaccine (inactivated, adjuvanted, adsorbed)
- COVID-19 Vaccine (recombinant, adjuvanted)
- CpG 1018/Alum-adjuvanted recombinant SARS-CoV-2 Trimeric Spike (S) protein subunit vaccine (SCB- 2019)
- crinecerfont
- Crisaborole
- crisaborole
- crisantaspase
- Crizanlizumab
- crizanlizumab
- crizotinib
- crofelemer
- cromoglicic acid
- Crovalimab
- crovalimab
- Cryptosporidium parvum, glycoprotein gp40
- cryptosporidium parvum, glycoprotein gp40
- culture expanded autologous chondrocytes
- CX-000359 mRNA encoding the UL128 protein in the CMV glycoprotein complex pentamer
- CX- 000594 mRNA encoding the gL protein in the CMV glycoprotein complex pentamer
- CX-000667 mRNA encoding CMV gB (mRNA- 1647)
- CX- 000712 mRNA encoding the UL130 protein in the CMV glycoprotein complex pentamer
- CX-005128 mRNA encoding the UL131A protein in the CMV glycoprotein complex pentamer
- CX-005282 m-RNA encoding the gH protein in the CMV glycoprotein complex pentamer
- CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2)
- cyamemazine
- cyanocobalamin
- cyclic GMP-AMP synthase inhibitor (BI 3000202)
- cyclizine
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone / ethinylestradiol
- cysteamine hydrochloride
- cysteine
- cystine
- cytarabine
- cytomegalovirus immunoglobulin
- D-Sorbitol (PXT3003)
- dabigatran etexilate
- dabigatran etexilate mesilate
- dabrafenib
- dabrafenib mesilate
- dacarbazine
- Daclatasvir
- daclatasvir
- daclatasvir dihydrochloride
- daclizumab
- dacomitinib
- dacomitinib monohydrate
- Dactylis glomerata L.
- dalbavancin
- dalbavancin hydrochloride
- dalcetrapib
- dalteparin sodium
- Damoctocog alfa pegol
- damoctocog alfa pegol
- danaparoid
- Danicopan
- danicopan
- danofloxacin
- danofloxacin mesilate
- dantrolene sodium, hemiheptahydrate
- danuglipron
- dapagliflozin
- dapagliflozin propanediol monohydrate
- Dapirolizumab pegol
- dapivirine
- dapoxetine
- daprodustat
- daptomycin
- daratumumab
- darbepoetin alfa
- Daridorexant
- daridorexant
- daridorexant hydrochloride
- darifenacin hydrobromide
- darolutamide
- darunavir
- darvadstrocel
- Dasabuvir
- dasabuvir
- Dasabuvir (sodium monohydrate)
- dasabuvir sodium
- dasatinib
- dasatinib (anhydrous)
- Dasatinib monohydrate
- Dasiglucagon
- dasiglucagon
- dasiglucagon hydrochloride
- dasiprotimut-t
- datopotamab deruxtecan
- daunorubicin
- daunorubicin hydrochloride
- davesomeran
- DaxibotulinumtoxinA
- dazukibart
- decitabine
- defatted powder of Arachis hypogaea L., semen (peanuts)
- deferasirox
- Deferiprone
- deferiprone
- Deferoxamine (mesylate)
- defibrotide
- degarelix
- degarelix acetate
- Delafloxacin
- delafloxacin
- delafloxacin meglumine
- Delamanid
- delamanid
- delandistrogene moxeparvovec
- delapril
- Deleobuvir
- Delgocitinib
- delgocitinib
- Delolimogene mupadenorepvec
- delta-9-tetrahydrocannabinol
- deltamethrin
- demeclocycline
- denecimig
- Dengue tetravalent vaccine (live, attenuated)
- dengue tetravalent vaccine (live, attenuated)
- Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated
- Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated
- Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
- Dengue virus, serotype 2, live, attenuated
- denosumab (29)
- Deoxycholic acid
- Depemokimab
- depigmented glutaraldehyde polymerised
- depreotide
- depreotide trifluoroacetate
- deproteinised hemoderivative of calf blood
- derivative of (3S,3'S,3a'S,10a'S)-3'-phenyl-3',3a',10',10a'-tetrahydro-1'H-spiro[indoline-3,2'- pyrrolo[2',3':4,5]pyrrolo[1,2-b]indazol]-2-one
- derivative of 1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- derivative of 3‐phenyl‐3H,4H,6H,7H‐pyrano[3,4‐d]imidazol‐4‐one
- derivative of 4,4'-(1-methylene)-bisbenzonitrile
- derivative of 4H-pyrazolo[3,4-d]pyrimidin-4-one
- derivative of 6-[2-(pyridin-2-yl)phenoxy]methyl}-1,2,3,4-tetrahydroisoquinoline
- derivative of 6‐(piperidine‐1‐carbonyl)pyridin‐3‐ol (BI 764198)
- derivative of a benzoimidazole substituted pyrimidine
- derivative of azabicycloheptane-carboxamide
- Derivative of pyrindin-2-yl)cyclopropanecarboxamide hydrochloride
- derivative of pyrrolopyrimidine
- dermatan sulfate
- Dermatophagoides farina
- Dermatophagoides farinae
- Dermatophagoides pteronyssinus
- dersimelagon
- desfluran
- desflurane
- desirudin
- desloratadine
- deslorelin acetate
- desmopressin
- desogestrel
- desoxycortone
- desoxycortone pivalate
- desvenlafaxine
- Desvenlafaxine succinate monohydrate
- detomidine
- deucravacitinib
- deucrictibant
- deutetrabenazine
- deutivacaftor
- deutivacaftor / tezacaftor / vanzacaftor
- dexamethasone
- dexamethasone (SHP640)
- Dexamethasone (sodium phosphate)
- dexamethasone acetate
- dexamethasone phosphate
- Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes
- dexamfetamine
- dexchlorpheniramine
- dexfadrostat phosphate
- dexfenfluramine
- dexibuprofen
- dexketoprofen
- Dexketoprofen (trometamol)
- dexlansoprazole
- dexmedetomidine
- Dexmedetomidine hydrochloride
- dexpanthenol
- dexpanthenol xylometazoline
- Dexpramipexole (dihydrochloride monohydrate)
- dexrazoxane
- dexrazoxane hydrochloride
- dextromethorphan
- Dextromethorphan (hydrobromide)
- dextromethorphan hydrobromide
- dextropropoxyphene
- Dezamizumab
- Diacerein
- diacerein
- diacerin
- Diamorphine
- diamorphine hydrochloride
- diazepam
- dibotermin alfa
- diclofenac
- diclofenac (potassium)
- diclofenac (sodium)
- diclofenac sodium
- diclofenamide
- didanosine
- Dienogest
- dienogest
- Difelikefalin
- difelikefalin
- difloxacin
- difloxacin hydrochloride
- diflunisal
- Dihomo-y-linolenic acid
- Dihomo-γ-linolenic acid (DS107)
- dihydroergocristine
- dihydroergocryptine
- dihydroergotamine
- dihydroergotoxine
- dihydroxyaluminum sodium carbonate
- diltiazem
- Diltiazem (hydrochloride)
- Dimeric protein comprised of two disulfide-linked monomers, each being a fully human fusion protein consisting of a modified extracellular domain of the human activin receptor type IIA fused to the fragment crystallizable domain of human IgG1 Fc including the hinge region, CH2 and CH3 domains (KER-050)
- dimethanesulfonate
- dimethyl fumarate
- Dimethyl sulfoxide
- dimeticone
- dinoprost
- dinoprostone
- dinotefuran
- dinotefuran, permethrin, and pyriproxyfen
- Dinutuximab
- dinutuximab
- Dinutuximab beta
- dinutuximab beta
- Dipalmitoylphosphatidylcholine
- dipalmitoylphosphatidylcholine
- diphenhydramine
- diphenhydramine hydrochloride
- diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed)
- diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) vaccine (adsorbed)
- diphtheria (D), tetanus (T), pertussis (whole cell) (Pw), hepatitis B (rDNA) (HBV), Haemophilus type b (HIB) and Neisseria meningitidis group A and C (MenAC) conjugate vaccine (adsorbed)
- diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed)
- diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
- diphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine
- diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)
- diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)
- diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed)
- diphtheria, tetanus and hepatitis B (rDNA) vaccine (adsorbed)
- diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)
- diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)
- diphtheria tetanus pertussis and poliomyelitis inactivated vaccine
- diphtheria tetanus pertussis and poliomyelitis inactivated vaccine reduce antigens content
- diphtheria tetanus vaccines
- diphtheria toxin interleukin-3 Fusion Protein
- Diphtheria toxoid
- diphtheria vaccine
- diptheria
- dipyridamole
- dirloctocogene samoparvovec
- dirlotapide
- diroximel fumarate
- Diroximel fumarate (BIIB098)
- Dirucotide acetate
- disitamab vedotin
- disulfide with human-Mus musculus monoclonal OG1950 kappa-chain
- DL-camphor
- DNA, d(P-thio)([2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]m5rC-[2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]rG-G-T-T-A-m5C-A-T-G-A-A-[2'-0-(2-methoxyethyl)]rA-[2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]m5rC-[2'-0-(2-methoxyethy l)]m5rC-[2'-0-(2-methoxyethyl)]m5rC), sodium salt
- DNA plasmid encoding HPV type 16 consensus E6 and E7 proteins (pGX 3001)
- DNA plasmid encoding HPV type 16 consensus E6 and E7 proteins (pGX3001)
- DNA plasmid encoding HPV type 18 consensus E6 and E7 proteins (pGX3002)
- Dobutamine
- docetaxel
- docetaxel trihydrate
- Docosahexaenoic acid
- docosanol
- dodecafluoropentane
- dofetilide
- dolutegravir
- Dolutegravir (DTG)
- dolutegravir sodium
- Domagrozumab
- domperidone
- domvanalimab
- donanemab
- donepezil
- donepezil hydrochloride
- Donidalorsen
- donidalorsen
- donidalorsen sodium
- Dopamine
- Dopamine (hydrochloride)
- dopamine hydrochloride
- doramectin
- doravirine
- Dordaviprone
- doripenem
- Doripenem monohydrate
- dornase alpha
- dorocubicel
- dorzolamide
- dostarlimab
- doxazosin
- doxazosin (mesylate)
- Doxecitine
- doxorubicin
- doxorubicin hydrochloride
- doxorubicin hydrochloride, liposomal
- Doxribtimine
- doxycycline
- doxycycline hyclate
- doxycycline monohydrate
- doxylamine
- Doxylamine (succinate)
- Drisapersen
- Dronabinol
- dronedarone
- drospirenone
- drotaverine hydrochloride
- drotrecogin alfa (activated)
- dry aqueous extract of paullinia cupana seed
- dry extract from birch bark (DER 5-10 : 1), extraction solvent n-heptane 95% (w/w)
- dry hydroethanolic extract of theobroma cacao seed
- dulaglutide
- duloxetine
- duloxetine hydrochloride
- dupilumab
- Durlobactam / sulbactam (SUL-DUR)
- durvalumab
- Dusquetide
- dutasteride
- duvelisib
- dydrogesterone-estradiol
- E. coli adhesin F4 (F4ab, F4ac, F4ad)
- E. coli adhesin F5
- E. coli adhesin F6
- E. coli adhesin F41
- E. coli verotoxoid vaccine (inactivated recombinant)
- E2 glycoprotein of classical swine fever virus
- ebastine
- ebola vaccine (Ad26.ZEBOV-GP [recombinant])
- Ebola vaccine (MVA-BN-Filo [recombinant])
- Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live)
- Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live)
- Ecallantide (recombiant inhibitor of human plasma kallikrein)
- econazole
- econazole nitrate
- ecopipam hydrochloride
- Eculizumab (2)
- eculizumab (1)
- edaravone
- edotreotide
- edoxaban
- edoxaban tosilate
- efalizumab
- Efanesoctocog alfa
- efanesoctocog alfa
- Efavaleukin alfa
- efavirenz
- efbemalenograstim alfa
- Efgartigimod alfa
- efgartigimod alfa
- Efinaconazole
- efinopegdutide
- Eflapegrastim
- eflornithine
- eflornithine hydrochloride
- eflornithine hydrochloride monohydrate
- efmoroctocog alfa
- Efpeglenatide
- Efruxifermin
- Eftilagimod alpha
- eftrenonacog alfa
- efungumab
- Efzofitimod
- EGFR-cMET bispecific antibody
- Eggdrop syndrome-1976 virus, strain BC14, inactivated
- egg drop syndrome virus vaccine (inactivated)
- Eimeria acervulina, strain 003
- Eimeria acervulina, strain 044, Live
- Eimeria acervulina, strain 044, live
- Eimeria brunetti, strain 034
- Eimeria maxima, strain 013
- Eimeria maxima, strain 013, Live
- Eimeria maxima, strain 013, live
- Eimeria mitis, strain 006
- Eimeria necatrix, strain 033
- Eimeria praecox, strain 007
- Eimeria praecox, strain 007, Live
- Eimeria praecox, strain 007, live
- Eimeria tenella, strain 004
- Eimeria tenella, strain 004, Live
- Eimeria tenella, strain 004, live
- elacestrant
- Elacytarabine
- Eladocagene exuparvovec
- eladocagene exuparvovec
- Elafibranor
- elafibranor
- Elagolix
- elasomeran
- elbasvir
- Eleclazine
- eletriptan
- elexacaftor
- Eliapixant
- eliglustat
- Eliglustat (tartrate)
- elinzanetant
- elivaldogene autotemcel
- Elobixibat
- Elocalcitol
- elosulfase alfa
- Elotuzumab
- elotuzumab
- elranatamab
- eltrombopag
- eltrombopag olamine
- eluxadoline
- elvitegravir
- emactuzumab
- emapalumab
- emedastine
- emedastine difumarate
- emicizumab
- emiplacel
- emixustat hydrochloride
- emodepside
- empagliflozin
- Empagliflozin / Derivative of 3‐phenyl‐3H,4H,6H,7H‐pyrano[3,4‐d]imidazol‐4‐one (BI 690517)
- empasiprubart
- Emricasan
- emtricitabine
- enalapril
- Enalapril (maleate)
- enalapril maleate
- Enasidenib
- encaleret
- encequidar
- enclomifene
- enclomifene citrate
- Encorafenib
- encorafenib
- enflicoxib
- Enfortumab vedotin
- enfortumab vedotin
- enfuvirtide
- enlicitide (decanoate)
- Enmetazobactam
- enmetazobactam
- enomimeran
- enoxacin
- enoxaparin
- enoxaparin sodium (2)
- Enpatoran
- enrofloxacin
- ensartinib
- ensifentrine
- ensitrelvir
- entacapone
- Entecavir
- entecavir
- entecavir monohydrate
- Entinostat Polymorph B
- Entolimod
- Entospletinib
- Entrectinib
- entrectinib
- enzalutamide
- enzastaurin hydrochloride
- Epcoritamab
- epcoritamab
- ephedrine
- ephedrine hydrochloride
- epinastine
- epinephrine
- epirubicin
- epizootic haemorrhagic disease vaccine (inactivated)
- epizootic haemorrhagic disease virus (EHDV), serotype 8, strain EHDV8 SPA 2022/LCV_03 LCV Cod.:O78
- eplerenone
- Eplivanserin hemifumarate
- eplontersen
- eplontersen sodium
- epoetin alfa (4)
- epoetin beta
- epoetin delta
- epoetin theta
- epoetin zeta (2)
- epoprostenol
- Epratuzumab
- eprinomectin
- eprinomectin, fipronil, praziquantel, (S)-methoprene
- eprodisate disodium
- eprosartan
- Eprotirome
- eptacog alfa (activated)
- eptacog alfa pegol (activated)
- Eptacog beta (activated)
- eptacog beta (activated)
- eptifibatide
- Eptinezumab
- eptinezumab
- eptotermin alfa
- Equine allogeneic mesenchymal stem cells
- equine herpesvirus 1, strain RAC-H and equine herpesvirus 4, strain 2252
- Equine herpesvirus vaccine (inactivated)
- Equine immunoglobulin F(ab')2 fragments targeting Shiga toxin
- equine influenza (live recombinant) and tetanus vaccine
- equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93
- equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid
- equine influenza vaccine (live recombinant)
- equine umbilical cord-derived mesenchymal stem cells
- equine umbilical cord mesenchymal stem cells
- eravacycline
- Erdafitinib
- erdafitinib
- Erdosteine
- erenumab
- ergocalciferol
- ergotamine
- Eribulin
- eribulin
- Eribulin mesylate
- Eritoran
- erlotinib
- ertapenem
- ertapenem sodium
- Ertugliflozin
- ertugliflozin
- ertugliflozin l-pyroglutamic acid
- Erysipelothrix rhusiopathiae
- Erysipelothrix rhusiopathiae, strain R32E11 (inactivated)
- erythromycin
- erythromycin estolate
- esafoxolaner
- Escherichia coli, type 08, strain K87 (live)
- Escherichia coli aroA gene deleted, type O78, strain EC34195 (live)
- escherichia coli bacteria (cells and autolysate)
- Escherichia coli J5 inactivated
- escherichia coli lysate
- escitalopram
- escitalopram oxalate
- Esketamine
- esketamine
- esketamine hydrochloride
- eslicarbazepine acetate
- esomeprazole
- esomeprazole magnesium
- esomeprazole magnesium trihydrate
- esomeprazole sodium
- essential oils of pine needle, eucalyptus and turpentine
- Estetrol
- estetrol
- estetrol monohydrate
- estradiol
- estradiol hemihydrate
- Estradiol valerate
- estriol
- eszopiclone
- Etamsylate
- etamsylate
- etanercept (3)
- Etarfolatide
- etavopivat
- Etelcalcetide
- etelcalcetide
- etelcalcetide hydrochloride
- eteplirsen
- Etesevimab
- Ethanol
- Ethinyl estradiol
- ethinyl estradiol
- ethinylestradiol
- ethinylestradiol bethadex clathrate
- ethosuximide
- ethyl alcohol
- ethyl loflazepate
- etidronate
- etidronic acid
- etifoxine
- etirinotecan pegol
- etomidate
- etonogestrel
- etoposide
- etoposide phosphate
- etoricoxib
- etoxybamide
- Etranacogene dezaparvovec
- etranacogene dezaparvovec
- etrasimod
- Etrasimod arginine
- Etrasimod L-arginine
- Etravirine
- etravirine
- Etripamil
- Etrolizumab
- Evacetrapib
- evenamide
- everolimus
- Evinacumab
- evinacumab
- Evobrutinib
- Evolocumab
- evolocumab
- Evoncabtagene pazurgedleucel
- Exagamglogene autotemcel
- exagamglogene autotemcel
- exametazime
- exanatide
- Exebacase
- exemestane
- exenatide
- exon 45 specific phosphorothioate oligonucleotide
- exon 53 specific phosphorothioate oligonucleotide
- expanded autologous bone marrow-derived osteoblastic cells
- expanded human autologous mesenchymal adult stem cells extracted from adipose tissue (CX-401)
- ExPEC9V
- ex vivo expanded autologous human corneal epithelial cells containing stem cells
- Ex vivo expanded autologous human corneal epithelium cells containing stem cells
- Ex vivo expanded autologous human keratinocytes containing epidermal stem cells genetically modified with a gamma-retroviral (RV) vector expressing the full-length LAMB3 cDNA (Hologene 5)
- ezeprogind
- ezetimibe
- F(ab’)2 fragments of equine antirabies immunoglobulin
- F4ab (K88ab) fimbrial adhesin
- F4ac (K88ac) fimbrial adhesin
- F5 (K99) fimbrial adhesin
- F6 (987P) fimbrial adhesin
- Factor VIII Inhibitor Bypassing Activity
- factor XIII
- faldaprevir
- famciclovir
- Famotidine
- Fampridine
- fampridine
- Faricimab
- faricimab
- Fasinumab
- fasudil hydrochloride
- Favezelimab
- fazirsiran
- Fc- and CDR-modified humanised monoclonal antibody against C5 (ravulizumab)
- febantel
- febuxostat
- fedratinib
- fedratinib dihydrochloride monohydrate
- felbamate
- feline calicivirosis, feline viral rhinotrachieitis, feline infectious enteritis (feline panleucopenia) vaccine (live), feline leukaemia vaccine (inactivated)
- feline calicivirus, strain 255, inactivated
- feline interleukin-2 recombinant canarypox virus (vCP1338 virus)
- feline leukaemia vaccine (inactivated)
- feline leukaemia virus recombinant canarypox virus (vCP97)
- feline panleucopenia virus, strain PLI IV, live
- feline rhinotracheitis virus, strain C27, antigen
- felodipine
- FeLV recombinant canarypox virus (vCP97)
- fenbendazole
- fenbutrazate
- Fenebrutinib
- fenfluramine
- fenfluramine hydrochloride
- fenofibrate
- fenoterol
- fenproporex
- fenspiride
- fentanyl
- fentanyl (transdermal patches, solution for injection - nationally authorised product only)
- Fentanyl citrate
- fentanyl citrate
- fentanyl hydrochloride
- ferric carboxymaltose
- ferric citrate coordination complex
- Ferric citrate coordination complex (FCCC)
- ferric derisomaltose
- ferric maltol
- Ferric pyrophosphate citrate
- Ferucarbotran
- Ferumoxytol
- ferumoxytol
- fesoterodine
- fesoterodine fumarate
- Fevipiprant
- Fexapotide (friflutate)
- fexinidazole
- fexofenadine
- fexofenadine hydrochloride
- fezolinetant
- Fianlimab
- fibrin
- fibrinogen
- fibrinogen (human plasma-derived)
- Fibroblast activation protein alpha-targeted interleukin 2 variant immunocytokine
- fibronectin
- fidanacogene elaparvovec
- fidaxomicin
- fidrisertib
- filamentous haemagglutinin
- filgotinib
- filgotinib maleate
- filgrastim (10)
- Finasteride
- finasteride
- Finerenone
- finerenone
- Fingolimod
- fingolimod
- fingolimod hydrochloride
- finrozole
- fipronil
- fipronil / amitraz / (S)-methoprene
- firocoxib
- Fish oil
- fitusiran
- Five component acellular pertussis [Purified Pertussis Toxoid (PT), Purified Filamentous Haemagglutinin (FHA), Purified Fimbriae Types 2 and 3 (FIM), and Purified Pertactin (PRN)]
- flecainide
- Flibanserin
- Florbetaben
- florbetaben (18F)
- florbetaben (18F)
- florbetapir (18F)
- florfenicol
- Flortaucipir (18F)
- flortaucipir (18F)
- Flortaucipir F18
- Flosfluridine tidoxil
- flubendazole
- fluciclovine (18F)
- flucloxacillin
- fluconazole
- flucytosine
- fludarabine
- fludeoxyglucose (18F)
- flumazenil
- flumequin
- flumequine
- flumethrin
- flunarizine
- flunisolide
- flunitrazepam
- flunixin
- Fluocinolone acetonide
- fluocinolone acetonide
- fluorescein
- Fluoride 18-labelled Prostate-Specific Membrane Antigen-1007 ([18F]PSMA-1007)
- Fluorine (18F) PSMA-1007
- Fluorocholine (18F)
- fluorodopa (18F)
- Fluoroestradiol (18F)
- fluoromisonidazole (18F)
- Fluoroquinolones
- Fluorouracil
- fluorouracil
- fluoxetine
- flupentixol
- flupirtine
- fluprednidene
- fluralaner
- flurbiprofen
- flurpiridaz (18F)
- flutamide
- flutemetamol (18F)
- fluticasone
- fluticasone furoate
- fluticasone propionate
- fluvastatin
- fluvoxamine
- folic acid
- follitropin alfa (2)
- follitropin beta
- follitropin delta
- Fomepizole
- fomivirsen
- fondaparinux sodium
- Fordadistrogene movaparvovec
- formaldehyde-inactivated whole-cell bacterial vaccine containing three strains of Actinobacillus pleuropneumoniae (serotypes 2, 9 and 11) and one strain of Pasteurella multocida (serotype A)
- formic acid
- formoterol
- Formoterol (fumarate)
- formoterol fumarate
- formoterol fumarate dihydrate
- forodesine hydrochloride
- fosamprenavir
- fosamprenavir calcium
- fosaprepitant
- foscarnet
- fosdenopterin
- fosdenopterin (ORGN001)
- fosdenopterin hydrobromide dihydrate
- fosfomycin
- fosfomycin calcium
- fosfomycin disodium
- fosfomycin sodium
- fosfomycin trometamol
- fosigotifator sodium tromethamine
- fosinopril
- Fosmanogepix
- fosmetpantotenate
- Fosnetupitant
- fosphenytoin
- Fostamatinib
- fostamatinib
- Fostamatinib disodium
- fostemsavir
- fostemsavir trometamol
- fowlpox, avian infectious laryngotracheitis vaccine (live, recombinant) and avian encephalomyelitis vaccine (live)
- fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)
- Freeze-dried allergen extract of Betula pendula pollen
- Freeze-dried culture of Lactobacillus casei subspecies rhamnosus Döderleini (Lcr35)
- fremanezumab
- frexalimab
- frovatriptan
- Frovatriptan (succinate monohydrate)
- frunevetmab
- fruquintinib
- Fully human IgG1 RB-1 YTE anti-RSV F monoclonal antibody (MK-1654)
- fulvestrant
- fulzerasib
- fumarate
- Funobactam
- Furosemide
- furosemide
- furosemide-spironolactone
- fusafungine
- fusidic acid
- Fusion protein composed of the first 2 immunoglobulin (Ig)-like domains of the human ROBO2 fused to human IgG1 Fc (PF-06730512)
- Fusion protein consisting of relaxin and Fc domain of IgG1
- Futibatinib
- futibatinib
- fuzuloparib
- gabapentin
- gadobenic acid
- Gadobutrol
- gadobutrol
- gadodiamide
- gadofosveset trisodium
- gadopentetic acid
- Gadopiclenol
- gadopiclenol
- Gadoquatrane (BAY 1747846)
- gadoteric acid
- gadoteric acid (IV and intravascular formulations)
- gadoteridol
- gadoversetamide
- gadoxetic acid
- gadoxetic acid disodium
- galantamine
- Galcanezumab
- galcanezumab
- Gallium (68Ga)
- gallium (68Ga) boclatixafortide
- gallium (68Ga) chloride
- Gallium 68-labelled Prostate-Specific Membrane Antigen-11 (68Ga-PSMA-11)
- galsulfase
- gamithromycin
- ganaxolone
- ganciclovir
- ganirelix
- ganirelix acetate
- gantenerumab
- garadacimab
- garenoxacin mesylate
- garetosmab
- gasiloxe
- GBP510
- gefapixant
- gefapixant (citrate)
- gefitinib
- gefurulimab
- gemcitabine
- gemcitabine hydrochloride
- gemfibrozil
- gemtuzumab ozogamicin
- genetically detoxified pertussis toxin (PTgen)
- genetically modified Mycobacterium bovis BCG
- genetically modified recombinant Shiga-toxin-2e antigen
- genetically modified replication-incompetent herpes simplex virus-1 expressing collagen VII (beremagene geperpavec)
- genetically modified Shiga-toxin-2e antigen
- gentamicin
- gentamicin (systemic use)
- gentamicin sulfate
- Gepotidacin
- germanium (68Ge) chloride
- gestodene
- Gevokizumab
- gilteritinib
- Gilteritinib (as fumarate)
- gilteritinib fumarate
- gimeracil
- gindameran
- GIPR antagonist/GLP-1R agonist (AMG 133)
- Giroctocogene fitelparvovec
- Givinostat
- givinostat
- givinostat hydrochloride monohydrate
- Givosiran
- givosiran
- Glasdegib
- glasdegib
- Glasdegib maleate
- glatiramer
- Glatiramer acetate
- glecaprevir
- Glepaglutide
- Gliadin protease
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- Glofitamab
- glofitamab
- Glu-NH-CO-NH-Lys-(Ahx)-[N,N9-bis[2-hydroxy-5-(carboxyethyl) benzyl]ethylenediamine-N,N9-diacetic acid (PSMA11-HBED-CC) (HBED Trasis)
- Glucagon
- glucagon
- glucagon analogue linked to a human immunoglobulin Fc fragment (HM15136)
- glucarpidase
- glucosamine
- glucosamine hydrochloride
- glucose
- glucose anhydrous
- glucose monohydrate
- glutamic acid
- Glutamine
- Glutathione
- glycerol
- Glycerol phenylbutyrate
- glycerol phenylbutyrate
- glyceryl trinitrate
- glycine
- glycine,L-alanine,L-arginine,L-aspartic acid,L-cysteine hydrochloride monohydrate,L-histidine,L-methionine,L-phenylalanine,L-proline,L-serine,L-threonine,L-tryptophan,L-tyrosine,L-glutamic acid,L-lysine monohydrate,taurine
- glycopyrronium
- glycopyrronium bromide
- glycyrrhiza glabra L., radix
- Gold (Au)
- Golidocitinib
- Golimumab (1)
- golimumab (1)
- gonadotropin releasing factor (GnRF) analogue-protein conjugate
- goserelin
- gotistobart
- govorestat
- gozetotide
- granisetron
- granisetron (other formulations except for transdermal patch)
- grapiprant
- grass pollen
- Grass pollen allergen extract from Dactylis glomerata L., Anthoxanthum odoratum L., Lolium perenne L., Poa prantensis L. and Phleum pratense L.
- grazoprevir
- grindelia soft extract
- grindelia tincture
- Guadecitabine
- guanfacine
- guanfacine hydrochloride
- Guselkumab
- guselkumab
- gusperimus
- gusperimus trihydrochloride
- H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH(YGRKKRRQRRRKLSSIESDV)
- haemagglutinin filamentous
- haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R,4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate (ECT-001-CB)
- haemoglobin glutamer-200 (bovine)
- haemophilus influenzae
- Haemophilus influenzae type b polysaccharide
- Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate)
- Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein
- Haemophilus influenzae type b polysaccharide conjugated to tetanus protein
- haemophilus type b and Meningococcal group C conjugate vaccine
- haemophilus type b and meningococcal group c conjugate vaccine
- haemophilus type b conjugate vaccine
- haemophilus type b conjugate vaccine (adsorbed)
- haemophilus type b conjugate vaccines
- haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine
- half-life extended bispecific T-cell engager (BiTE) antibody construct that binds to prostate-specific membrane antigen and cluster of differentiation 3, with a single chain fragment crystallizable moiety
- halofantrine
- halofuginone
- haloperidol
- haloperidol decanoate
- hazel pollen
- Hemoglobin betafumaril (bovine)
- Hemopexin
- heparin (sodium)
- heparin sodium
- hepatitis a
- hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)
- hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
- hepatitis A vaccines
- hepatitis A virus (inactivated)
- hepatitis A virus (inactivated, adsorbed)
- Hepatitis B (rDNA) surface antigen adjuvanted
- hepatitis B, recombinant surface antigen
- hepatitis B recombinant vaccine, adsorbed
- hepatitis B surface antigen
- hepatitis B surface antigen (rDNA)
- Hepatitis B Surface Antigen, recombinant
- hepatitis B surface antigen produced in yeast cells
- hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells]
- hepatitis B vaccine (rDNA)
- hepatitis B vaccine (recombinant DNA)
- hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
- hepatitis A virus (inactivated)
- hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
- hepatitis B recombinant surface antigen
- hepatitis B surface antigen recombinant
- Herpes simplex 1 virus thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes
- herpes zoster vaccine (recombinant, adjuvanted)
- heterologous human adult liver-derived progenitor cells
- hexamidine
- hexaminolevulinate
- hexaminolevulinate hydrochloride
- hexoprenaline
- hexoprenaline sulfate
- highly refined fish oil
- histamine dihydrochloride
- histidine
- histrelin acetate
- HIV-1 Maturation Inhibitor (GSK3640254)
- House dust mites allergen extracts
- Human-cell-line recombinant human factor VIII (human-cl rhFVIII)
- Human-papillomavirus-type-6 L1 protein
- human-papillomavirus-type-11 L1 protein
- human-papillomavirus-type-16 L1 protein
- human-papillomavirus-type-18 L1 protein
- human-papillomavirus-type-31 L1 protein
- human-papillomavirus-type-33 L1 protein
- human-papillomavirus-type-45 L1 protein
- human-papillomavirus-type-52 L1 protein
- human-papillomavirus-type-58 L1 protein
- human albumin, denatured
- human alfa1-proteinase inhibitor (apart from the centrally authorised product)
- human alpha-1 proteinase inhibitor, modified (SerpinPC)
- human alpha-1-proteinase inhibitor immunoglobulin G fusion protein, recombinant
- human alpha1-proteinase inhibitor
- human anti-d immunoglobulin
- human anti-interleukin-15 (IL-15) monoclonal antibody
- human autologous mesenchymal adult stem cells extracted from adipose tissue
- human chorionic gonadotrophin
- human ciliary neurotrophic factor
- human clottable protein containing mainly fibrinogen and fibronectin, calcium chloride
- human coagulation factor IX
- human coagulation factor VII
- human coagulation factor VIII
- human coagulation factor VIII (inhibitor bypassing fraction)
- human Coagulation Factor VIII (rDNA)
- human coagulation factor VIII / human von willebrand factor
- human coagulation factor X
- human coagulation factor XIII
- human coagulation factor XIII, human fibrinogen
- human dermal fibroblasts cultured on bioresorbable polyglactin mesh (ABH001)
- human donor haematopoietic stem and progenitor cells (HSPC) that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor (TBX-1400)
- human factor XIII
- human factor xiii
- human fibrinogen
- human fibrinogen, human thrombin
- human fibrinogen concentrate (BT524)
- human hemin
- human hepatitis B immunoglobulin
- human heterologous liver cells
- human hydroxysteroid-17ß-dehydrogenase type 1 (HSD17B1) enzyme inhibitor
- human IgG1 monoclonal antibody specific for human interleukin-1 alpha
- human IgG4 monoclonal antibody against BCMA and CD3 (ABBV-383)
- human IgG4-based bispecific antibody binding to both B-cell maturation antigen (BCMA) and cluster of differentiation 3 (CD3) (REGN5458)
- human immunoglobulin (Ig) G4-variant monoclonal antibody that binds and neutralizes soluble human interleukin (IL-) 33
- human immunoglobulin G1 constant region - human ectodysplasin-A1 receptor-binding domain fusion protein
- human immunoglobulin G2 isotype antibody to IL-33R
- human insulin
- human insulin (rDNA)
- Humanised Antibody Targeting the Inducible T cell Co-Stimulatory receptor
- Humanised chimeric antibody with a humanised H chain and a chimeric (mouse V-domain, human C-domain) L chain against epidermal growth factor receptor conjugated to maleimidocaproyl monomethylauristatin F (ABT-414)L chain against epidermal growth factor receptor conjugated to maleimidocaproylmonomethylauristatin F (ABT-414)
- humanised IgG1 monoclonal antibody against integrin beta-6 conjugated to monomethyl auristatin E via a valine-citrulline linker (SGN-B6A)
- humanised IgG1 monoclonal antibody against TROP2, conjugated to a topoisomerase I inhibitor belotecan-derivative
- humanised IgG1kappa Monoclonal Antibody directed against IGF-1R
- Humanised IgG2k Fc-modified bispecific antibody against CD3 and BCMA (PF-06863135)
- Humanised IgG4 monoclonal antibody against extracellular tau (BMS-986168)
- Humanised KLB/FGFR1c monoclonal antibody (MK-3655)
- Humanised monoclonal antibody derivative against fibroblast growth factor receptor 3 (SAR442501)
- Humanised recombinant IgG4, Anti-PD-1 monoclonal antibody (CS1003)
- Humanized anti-CD19, Fc engineered, monoclonal antibody (XmAb5871)
- Humanized antibody targeting B cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F
- Humanized IgG1 blocking monoclonal antibody targeting CD39 (IPH5201)
- Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody
- Humanized immunoglobulin (lg) G4 proline, alanine, alanine (IgG4 PAA) based bispecific antibody directed against cluster of differentiation (CD) 3 receptor complex and B-cell maturation antigen (BCMA)
- Humanized monoclonal antibody of IgG1 sub-type targeting the human SEMA3A polypeptide
- Humanized monoclonal antibody of IgG1 subtype targeting NRP1
- Humanized recombinant IgG4 anti-human tau antibody
- human monoclonal antibody targeting Staphylococcus aureus alpha-toxin (tosatoxumab)
- human Neutrophil Elastase Inhibitor (CHF6333)
- human normal immunoglobulin
- human normal immunoglobulin (IVIg)
- human normal immunoglobulin (SCIg)
- human normal immunoglobulin (SCNG20%)
- human normal immunoglobulins
- human Papillomavirus1 Type 6 L1 protein
- human Papillomavirus1 Type 11 L1 protein
- human papillomavirus1 type 16 L1 protein
- human Papillomavirus1 Type 18 L1 protein
- human papillomavirus 9-valent vaccine (recombinant, adsorbed)
- human papillomavirus type 6 L1 protein
- human papillomavirus type 11 L1 protein
- human papilloma virus type 16 E6 001-032
- human Papilloma Virus Type 16 E6 019-050
- human Papilloma Virus Type 16 E6 041-065
- human papilloma virus type 16 E6 055-080
- human papilloma virus type 16 E6 071-095
- human Papilloma Virus Type 16 E6 085-109
- human papilloma virus type 16 E6 091-122
- human Papilloma Virus Type 16 E6 109-140
- human Papilloma Virus Type 16 E6 127-158
- human Papilloma Virus Type 16 E7 001-035
- human Papilloma Virus Type 16 E7 022-056
- human papilloma virus type 16 E7 064-098
- human papillomavirus type 16 L1 protein
- human papillomavirus type 18 L1 protein
- human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed)
- human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
- human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
- human plasma (pooled and treated for virus inactivation)
- Human plasma derived C1-inhibitor (OCTA-C1-INH)
- human plasma protease C1 inhibitor
- Human plasma proteins
- human plasma proteins with no less than 95% albumin
- human protein C
- human prothrombin complex
- human rabies immunoglobulin
- Human recombinant follicle-stimulating hormone (FE 999049)
- Human recombinant interleukin-2
- human rotavirus, live attenuated
- human tetanus immunoglobulin
- human thrombin
- human thrombin, aprotinin
- human von willebrand factor
- hyaluronidase
- hydrochlorothiazide
- hydrochlorothiazide moexipril
- hydrocortisone
- hydrocortisone (hemisuccinate)
- hydrocortisone aceponate
- Hydrogen peroxide
- hydromorphone
- hydromorphone (hydrochloride)
- hydroquinidine
- hydroxocobalamin
- hydroxycarbamide
- hydroxychloroquine
- hydroxyethyl salicylate
- hydroxyethyl starch
- hydroxyprogesterone caproate
- hydroxypropyl-β-cyclodextrin
- hydroxyzine
- hydroxyzine chloride
- hydroxyzine pamoate
- hyoscine
- hypericum perforatum L., herba
- ibafloxacin
- Ibalizumab
- ibalizumab
- ibandronic acid
- Iberdomide
- iberis amara L., planta tota recens
- Ibodutant
- Ibrexafungerp
- Ibrexafungerp citrate
- ibritumomab tiuxetan
- Ibrutinib
- ibrutinib
- Ibuprofen
- ibuprofen
- Ibuprofen (sodium dihydrate)
- ibuprofen lysine
- Ibutamoren mesilate
- ibutilide
- icatibant
- icatibant acetate
- iclepertin
- icodextrin
- Icosabutate
- Icosapent
- Icosapent ethyl
- icosapent ethyl
- Icosasodium{26-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]-14,14-bis{[(3-{6-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]hexyl}amino)-3-oxopropoxy)]methyl}-8,12,19-trioxo-16-oxa-7,13,20-triazahexacosyl}2′-O-(2-methoxyethyl...
- idarubicin
- idarucizumab
- Idasanutlin
- idebenone
- idecabtagene vicleucel
- Idelalisib
- idelalisib
- Idrevloride
- idroxioleic acid
- idursulfase
- Ifinatamab deruxtecan
- ifosfamide
- igovomab
- IIgG-like T cell engager binding to DLL3 and CD3
- Ilginatinib maleate
- iloperidone
- iloprost
- ilunocitinib
- imatinib
- imatinib mesilate
- Imdevimab
- imdevimab
- imelsomeram
- imepitoin
- imetelstat
- IMG-2789
- imidacloprid
- imidapril
- imiglucerase
- imipenem
- imipenem monohydrate
- imipramine
- imiquimod
- imlifidase
- imlunestrant
- imlunestrant tosilate
- Immunoglobulin G1 anti-SORT1 human monoclonal antibody
- immunoglobulin G4 [224-proline], anti-(Betula alleghaniensis allergen Bet v 1) (human monoclonal REGN5713 γ4-chain), disulphide with human monoclonal REGN5713 κ-chain, dimer (REGN5713)
- immunoglobulin G4 [227-proline], anti-(Betula alleghaniensis allergen Bet v 1) (human monoclonal REGN5714 γ4-chain), disulphide with human monoclonal REGN5714 κ-chain, dimer (REGN5714)
- immunoglobulin G4 [228-proline], anti-(Betula alleghaniensis allergen Bet v 1) (human monoclonal REGN5715 γ4-chain), disulphide with human monoclonal REGN5715 κ-chain, dimer (REGN5715)
- immunoglobulin G4 [449-cysteine]
- inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections
- inactivated avian infectious bronchitis virus, type 793/B, strain 4-91
- inactivated avian infectious bronchitis virus, type Massachusetts, strain M41
- inactivated avian reovirus strain ARV-1
- inactivated avian reovirus strain ARV-4
- inactivated bluetongue serotype 1+8 vaccine
- inactivated bluetongue virus, serotype-1
- inactivated bluetongue virus, serotype 1
- Inactivated bluetongue virus, serotype 1, strain ALG2006/01 E1
- inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01
- inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1 RP
- inactivated bluetongue virus, serotype 3
- Inactivated bluetongue virus, serotype 4, strain BTV-4/SPA-1/2004
- inactivated bluetongue virus, serotype 8
- Inactivated bluetongue virus, serotype 8, strain BEL2006/01
- inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02
- inactivated bluetongue virus, serotypes 1 and 8
- inactivated Bordetella bronchiseptica, strain 833CER
- inactivated Bordetella bronchiseptica cells
- inactivated Bordetella pertussis
- inactivated Bovine Viral Diarrhoea (BVD) type 1 virus, cytopathogenic strain 5960
- inactivated chimaeric flavivirus strain YF-WN
- inactivated Coxiella burnetii vaccine
- inactivated Coxiella burnetii vaccine, strain Nine Mile
- inactivated feline calicivirosis antigens (FCV 431 and G1 strains)
- inactivated feline calicivirus
- inactivated feline Chlamydophila felis
- inactivated feline leukaemia virus
- inactivated feline panleukopenia virus
- inactivated feline panleukopenia virus, calicivirus, rhinotracheitis virus, leukaemia virus and Chlamydophila felis
- inactivated feline rhinotracheitis virus
- inactivated fimbrial adhesins of Escherichia coli
- Inactivated fimbrial adhesins of Escherichia coli F4ab
- Inactivated fimbrial adhesins of Escherichia coli F4ac
- Inactivated fimbrial adhesins of Escherichia coli F5
- Inactivated fimbrial adhesins of Escherichia coli F6
- inactivated Histophilus somni Bailie strain
- inactivated IBR virus
- inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain
- inactivated infectious bursal disease virus, strain 89/03
- Inactivated infectious bursal disease virus, strain GB02
- inactivated influenza-A virus
- inactivated influenza-A virus / swine
- Inactivated Leptospira strains: L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000); L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001); L. interrogans serogroup Australis serovar Bratislava (strain As-05-073); L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
- inactivated leptospire vaccine
- Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
- inactivated patients own (autologous) microorganism (Escherichia coli, Candida spp., Enterococcus spp., Streptococcus spp., Staphylococcus spp., Prevotella intermedia, Fusobacterium nucleatum and others)
- inactivated porcine actinobacillosis vaccine
- inactivated porcine circovirus type 2 (PCV2)
- inactivated porcine circovirus vaccine
- inactivated rabbit haemorrhagic disease type 2 virus (RHDV2), strainV-1037
- inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein
- inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein
- inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein
- inactivated Schmallenberg virus, strain BH80/11-4
- Inactivated Type 1 poliovirus (Brunhilde)
- Inactivated Type 1 Poliovirus (Mahoney)
- Inactivated Type 2 Poliovirus (MEF-1)
- Inactivated Type 3 Poliovirus (Saukett)
- inactivated vaccine against bluetongue virus serotypes 1 and 8
- inactivated vaccine against foot-and-mouth disease
- inactivated vaccine against yersiniosis
- inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs
- inactivated West Nile virus, strain VM-2
- inactivated whole avian influenza virus antigen of H5 subtype (strain H5N6, A/duck/Potsdam/2243/84)
- inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86)
- inactivated whole avian influenza virus antigen of H7N1 subtype (strain, A/CK/Italy/473/99)
- inactivated whole cell concentrate of Mycoplasma hyopneumoniae strain 11
- inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A, strain B3263/91
- inavolisib
- Inaxaplin
- inclacumab
- inclisiran
- Inclisiran sodium
- indacaterol
- Indacaterol (acetate)
- indacaterol acetate
- indacaterol maleate
- Indapamide
- indapamide (hemihydrate)
- indinavir
- indinavir sulfate ethanolate
- indium (111In) pentetate
- indium (In-111) chloride
- indium (In-111) oxine
- indobufen
- indocyanine green
- indometacin
- indoramin
- indoxacarb
- Inebilizumab
- inebilizumab
- infectious bovine rhinotracheitis vaccine (inactivated)
- infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, live
- infectious bronchitis
- infectious bronchitis virus, type 793/B, strain 4/91, inactivated
- infectious bronchitis virus, type Massachusetts, strain M41, inactivated
- infectious bursal disease
- Infectious bursal disease virus, strain 89/03, inactivated
- Infectious bursal disease virus, strain GB02, inactivated
- Infigratinib
- infigratinib
- Infigratinib monophosphate
- infliximab (5)
- Influenza A virus/human strain: A/Jena/VI5258/2009 (H1N1)pdm09, inactivated
- Influenza A virus subtype H1N1 haemagglutinin, recombinant
- Influenza A virus subtype H3N2 haemagglutinin, recombinant
- Influenza B virus Victoria lineage haemagglutinin, recombinant
- Influenza B virus Yamagata lineage haemagglutinin, recombinant
- Influenza recombinant H7 haemagglutinin
- influenza vaccine
- influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
- influenza vaccine (H1N1)v (whole virion, Vero cell derived, inactivated)
- influenza vaccine (live attenuated, nasal)
- influenza vaccine (split virion, inactivated)
- influenza vaccine (split virion, inactivated) (non centrally authorised products)
- Influenza vaccine (split virion, inactivated, prepared in cell cultures)
- influenza vaccine (surface antigen, inactivated)
- influenza vaccine (surface antigen, inactivated, adjuvanted)
- influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
- influenza vaccine (surface antigen, inactivated, prepared in cell cultures) [QIVc]
- influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1)
- influenza vaccine, purified antigen
- influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)
- influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type)
- Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1)
- Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen
- influenza virus A/Victoria/4897/2022 (H1N1)pdm09 - like strain (A/Norway/31694/2022, MEDI 369815), A A/Croatia/10136RV/2023 (H3N2)-like strain (A/Perth/722/2024, MEDI 392611) B/Austria/1359417/2021 - like strain (B/ Austria/1359417/2021, MEDI 355292)
- Influenza virus H1 haemagglutinin
- influenza virus H3 haemagglutinin
- influenza virus haemagglutinin from strain B Victoria lineage
- influenza virus haemagglutinin from strain B Yamagata lineage (expressed as virus-like particle [VLP])
- Influenza virus inactivated split virion (haemagglutinin and neuraminidase) of strain A (H1N1)
- Influenza virus inactivated split virion (haemagglutinin and neuraminidase) of strain A (H3N2)
- Influenza virus inactivated split virion (haemagglutinin and neuraminidase) of strain B (Victoria lineage)
- Influenza virus inactivated split virion (haemagglutinin and neuraminidase) of strain B (Yamagata lineage)
- Influenza virus surface antigens (haemagglutinin) of strain A (H1N1)
- influenza virus surface antigens (haemagglutinin) of strain A (H3N2)
- influenza virus surface antigens (haemagglutinin) of strain B (Yamagata lineage)
- influenza virus surface antigens (haemagglutinin) of strain B (Victoria lineage)
- influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type)
- Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains: A/Solomon Islands/3/2006 (H1N1)-like strain (A/Solomon Islands/3/2006, IVR-145); A/Wisconsin/67/2005 (H3N2)-like strain (A/Wisconsin/67/2005, NYMC X161B); B/Malaysia/2506/2004-like strain (B/Malaysia/2506/2004)
- Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, trivalent
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181
- influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A (H1N1)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A (H3N2)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/H1N1Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/H3N2Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/H5N1
- influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B (Victoria lineage)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B (Yamagata lineage)
- Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains: A/(H1N1), A/(H3N2), B/Yamagata lineage, B/Victoria lineage
- influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1)
- Influenza virus surface antigens - A/turkey/Turkey/1/05 (H5N1)
- Influenza virus type A, H1N1
- influenza virus type A, H3N2
- Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B
- Influenza virus Type A H1N1, whole virion, inactivated
- Influenza virus Type A H3N2, whole virion, inactivated
- influenza virus type B, Victoria lineage
- Influenza virus Type B, whole virion, inactivated
- influenza virus type B, Yamagata lineage
- Ingenol mebutate
- ingenol mebutate
- Inhibitor of receptor-interacting protein kinase 1 (ABBV-668)
- Inhibitor of receptor-interacting serine/threonine-protein kinase 1 (SAR443820)
- inobrodib
- inosine dimepranol acedoben
- inosine pranobex
- inotersen
- inotersen sodium
- Inotuzumab ozogamicin
- inotuzumab ozogamicin
- Insulin 287
- insulin aspart (4)
- insulin degludec
- Insulin detemir
- insulin detemir
- Insulin efsitora alfa
- insulin glargine (4)
- insulin glulisine
- Insulin human (2)
- insulin human (2)
- Insulin human (NTRA-2112)
- insulin human (rDNA) (1)
- Insulin human (RDNA)
- insulin icodec
- insulin lispro (1)
- Insulin lispro (BC222)
- Insulin peglispro
- insulin porcine
- interferon (omega)
- interferon alfa-2a (1)
- interferon alfa-2b
- interferon alfacon-1
- interferon alpha-2a
- Interferon alpha 2b
- interferon beta-1a
- interferon beta-1b
- Interferon gamma
- Interleukin-2/Interleukin-1 beta, human/Granulocyte colony-stimulating factor/Tumour necrosis factoralpha/ Interferon gamma
- interleukin-23 receptor antagonist peptide
- Invimestrocel
- in vitro expanded autologous human articular chondrocytes
- iobitridol
- iodine
- iodine (131-I) murine IgG1 monoclonal antibody against B7-H3 (131I-omburtamab)
- iodine (131I) apamistamab
- Iodine (131I) iobenguane
- iodine (131I) omburtamab
- iodixanol
- iodocasein
- ioflupane (123I)
- ioflupane (123i)
- ioflupane (123l)
- Ioforminol
- iohexol
- iomeprol
- iopamidol
- iopromide
- ioxaglic acid
- Ipatasertib
- ipidacrine
- Ipilimumab
- ipilimumab
- ipratropium
- ipratropium salbutamol
- iptacopan
- iptacopan hydrochloride monohydrate
- irbesartan
- irbesartan hydrochloride
- irinotecan
- irinotecan anhydrous free-base
- irinotecan hydrochloride trihydrate
- iron
- Iron(iii) ion
- iron (III) ion
- Iron, aqua carbonate hydroxy oxo starch sucrose complex
- iron dextran
- Iron hydroxyethyl amylopectin heptonate
- iron isomaltoside
- iron oxide
- iron sucrose
- Isatuximab
- isatuximab
- isavuconazole
- Isavuconazonium sulfate
- Iscalimab
- Islatravir
- Isoflurane
- Isoleucin
- isoleucine
- isoniazid
- isopropyl alcohol
- isotretinoin
- isotretinoin (oral formulations)
- isotretinoin (topical formulations)
- isoxsuprine
- Istradefylline
- istradefylline
- Itacitinib
- Itolizumab
- itopride
- Itraconazole
- itraconazole
- ivabradine
- ivabradine hydrochloride
- ivacaftor
- ivacaftor / tezacaftor/ potassium (benzenesulfonyl)({[6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridin-3-yl]carbonyl})azanide (VX-659)
- ivermectin
- ivonescimab
- Ivosidenib
- ivosidenib
- Ixazomib
- ixazomib
- ixazomib citrate
- ixekizumab
- Izaflortaucipir (18F)
- izencitinib
- izenivetmab
- izokibep
- Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)
- Japanese encephalitis vaccine (inactivated, adsorbed)
- Japanese encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)
- ketamine
- ketamine (hydrochloride)
- ketobemidone
- Ketoconazole
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac trometamol (OMS302)
- ketotifen
- klebsiella ozaenae
- klebsiella pneumoniae
- L-5-methyltetrahydrofolic acid, calcium salt
- L-acetylleucine
- L-arginine hydrochloride
- L-Asparaginase
- L-asparaginase encapsulated in erythrocytes
- L-carnitine
- L-Cysteine, L-leucyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-α -aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin
- L-Cysteinyl-L-prolyl-L-alanyl-L-valyl-L-lysyl-L-arginyl-L-aspartyl-L-valyl-L-aspartyl-L-leucyl-L-phenylalanyl-L-leucyl-L-threonine, acetate salt
- L-glutamyl-L-glutaminyl-L-valyl-L-alanyl-Lglutaminyl-L-tyrosyl-L-lysyl-L-alanyl-L-leucyl-L-prolyl-L-valyl-L-valyl-L-leucyl-L-glutamyl-L-asparaginyl-L-alanine, acetate salt
- L-Lactic acid
- L-lysine hydrochloride
- L-lysyl-L-alanyl-L-leucyl-L-prolyl-L-valyl-L-valyl-L-leucyl-L-glutamyl-L-asparaginyl-L-alanyl-L-arginyl-L-isoleucyl-L-leucyl-L-lysyl-L-asparaginyl-L-cysteinyl-L-valine, acetate salt...
- L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
- L. interrogans serogroup Australis serovar Bratislava (strain As-05-073)
- L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
- L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
- labetalol
- lacidipine
- lacosamide
- lactic acid
- lactitol
- lactobacillus all subspecies and combinations of subspecies
- Lactobacillus reuteri (IBP-9414)
- lactobionic acid
- lactulose
- Lacutamab
- Ladarixin
- lademirsen
- lamivudine
- lamotrigine
- lanadelumab
- Lanadelumab (DX-2930)
- lanalumab
- landiobloc
- landiolol
- landiolol hydrochloride
- lanreotide
- Lanreotide acetate
- lansoprazole
- lanthanum
- Lanthanum carbonate hydrate
- lapatinib
- Lapatinib ditosilate monohydrate
- laquinimod
- Laquinimod (sodium)
- laronidase
- laropiprant
- Larotrectinib
- larotrectinib
- larotrectinib sulfate
- laruparetigene zovaparvovec
- Larvae of Lucilia sericata
- lasmiditan
- lasmiditan succinate
- lasofoxifene
- Lasofoxifene tartrate
- Latanoprost
- latanoprost
- latanoprost / netarsudil
- Latozinemab
- lavender oil
- lazertinib
- lazertinib (mesilate)
- lazertinib mesilate monohydrate
- Lebrikizumab
- lebrikizumab
- Lecanemab
- lecanemab
- ledipasvir
- ledispavir
- Lefamulin
- lefamulin
- lefamulin acetate
- leflunomide
- Leishmania infantum excreted secreted proteins
- lenacapavir
- lenacapavir sodium
- lenadogene nolparvovec
- lenalidomide
- lenalidomide hydrochloride hydrate
- lenalidomide hydrochloride monohydrate
- Leniolisib
- lenograstim
- Lentiviral vector containing the human ABCA4 gene
- lenvatinib
- lenvatinib mesilate
- lepirudin
- Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated,Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated,Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated,Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated,
- Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090, L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091 (all inactivated)
- Leptospira interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000)
- lercanidipine
- leriglitazone
- leriglitazone hydrochloride
- lerociclib (dihydrochloride)
- Lerodalcibep
- lesinurad
- Letermovir
- letermovir
- letrozole
- leucine
- leucine L
- leuprorelin
- leuprorelin (depot formulations)
- leuprorelin mesilate
- levacetylmethadol
- levamisole
- levamisole hydrochloride
- levetiracetam
- levobunolol
- levobupivacaine
- levocabastine
- levocetirizine
- levocetirizine (dihydrochloride)
- levodopa
- levodropropizine
- levofloxacin
- levofloxacin/dexamethasone (ocular use)
- Levofloxacin hemihydrate
- Levomenthol
- levomenthol
- levomethadone
- levomilnacipran
- levonorgestrel
- levosalbutamol
- Levosimendan
- levothyroxine
- Levothyroxine (sodium)
- levothyroxine sodium
- lidocaine
- lidocaine hydrochloride
- lifileucel
- Lifitegrast
- ligelizumab
- linaclotide
- linagliptin
- lincomycin
- Linerixibat
- linezolid
- linvoseltamab
- linzagolix choline
- liothyronine
- lipegfilgrastim
- liposomal ciclosporin A (L-CsA)
- liposomal vinorelbine (tartrate)
- Lipoteichoic acid from Biofilm Adhesion Component of Streptococcus uberis, strain 5616
- liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit
- Liquid ethanolic extract 30 per cent (w/w) of Allium cepa L. (fresh bulb) and Citrus limon (L.) Burm. f. (fresh fruit)
- liraglutide
- lisdexamfetamine
- Lisdexamfetamine dimesilate
- lisdexamfetamine dimesylate
- lisinopril
- lisinopril (dihydrate)
- Lisocabtagene maraleucel
- lisocabtagene maraleucel
- lisuride
- lithium
- Litoxetine (benzoate)
- live, attenuated, chimeric dengue virus, serotype 1
- live, attenuated, chimeric dengue virus, serotype 2
- live, attenuated, chimeric dengue virus, serotype 2 (DENV2)
- live, attenuated, chimeric dengue virus, serotype 3
- live, attenuated, chimeric dengue virus, serotype 4
- Live, attenuated, dengue virus, serotype 1 (DENV1)
- Live, attenuated, dengue virus, serotype 3 (DENV3)
- Live, attenuated, dengue virus, serotype 4 (DENV4)
- live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated
- live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated and Leptospira
- Live-attenuated La Reunion strain of chikungunya virus (VLA1553)
- Live aroA gene deleted Escherichia coli, type 078, strain EC34195
- live attenuated Aujeszky's disease virus
- live attenuated avian infectious bronchitis virus variant strain 4-91
- live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56
- Live attenuated canine distemper virus strain Onderstepoort: 105.1 – 106.5 TCID50
- live attenuated infectious bursal disease virus (IBDV), strain 1052
- live attenuated Muscovy duck parvovirus
- live attenuated poliovirus type 1
- live attenuated poliovirus type 3
- live attenuated PRRS virus strain DV
- live attenuated rabies virus, SAG2 strain
- live attenuated respiratory syncytial virus (RSV)
- live attenuated vaccine against avian infectious bronchitis
- live attenuated varicella virus (OKA strain)
- live attenuated yellow fever virus
- live avian infectious bronchitis virus, strain D388
- Live bacterium B. thetaiotaomicron
- live Bordetella bronchiseptica bacteria strain B-C2
- live deletion-mutant Streptococcus equi strain TW928
- live feline calicivirus (strain F9)
- live feline panleucopenia virus
- live feline viral rhinotracheitis virus (strain F2)
- live gE- tk- double-gene-deleted bovine herpes virus type 1, strain CEDDEL: 106.3–107.3 CCID50
- live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis
- live infectious bursal disease virus, strain V877
- live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009
- Live myxoma vectored RHD virus strain 009
- Live myxoma vectored RHD virus strain MK1899
- live non-pathogenic Escherichia coli O8:K87
- Live non-pathogenic Escherichia coli O141:K94 (F18ac) and O8:K87 (F4ac)
- Live recombinant canine parvovirus strain 630a: 105.1 – 106.7 TCID50
- Live Recombinant E2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus E2 gene (CP7_E2alf)
- live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rFP-LT) and avian encephalomyelitis virus, strain Calnek 1143 (AE)
- Live recombinant Marek’s disease (MD) virus, serotype 1, strain RN1250
- Live recombinant Marek’s disease virus, serotype 1, strain RN1250; Live recombinant turkey herpesvirus, expressing the VP2 protein of infectious bursal disease virus, strain vHVT013-69
- Live recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV
- live vaccine against Bordetella bronchiseptica in cats
- live vaccine against rabies
- live vaccine against Streptococcus equi
- Livoletide
- lixisenatide
- Lixivaptan
- locatim, oral solution for neonatal calves less than 12 hours of age
- lokivetmab
- Lolium perenne
- Lolium perenne L.
- lomefloxacin
- Lomitapide
- lomitapide
- lomustine
- Lonafarnib
- lonafarnib
- Lonapegsomatropin
- lonapegsomatropin
- Loncastuximab tesirine
- loncastuximab tesirine
- lonoctocog alfa
- loperamide
- lopinavir
- loratadine
- lorazepam
- Lorcaserin
- Lorlatinib
- lorlatinib
- lormetazepam
- lornoxicam
- losartan
- Losartan potassium
- Losmapimod
- loteprednol
- lotilaner
- lotilaner / milbemycin oxime
- lovastatin
- loxapine
- loxoprofen (sodium hydrate)
- LT toxoid
- Lubiprostone
- lucerastat
- Lumacaftor
- lumacaftor
- lumasiran
- Lumasiran (ALN-GO1)
- Lumasiran sodium
- lumefantrin
- lumefantrine
- Lumicitabine
- lumiracoxib
- lurasidone
- Lurasidone hydrochloride
- Lurbinectedin
- Luspatercept
- luspatercept
- Lusutrombopag
- lusutrombopag
- lutetium (177Lu)
- lutetium (177Lu) chloride
- Lutetium (177Lu) edotreotide
- lutetium (177Lu) oxodotreotide
- lutetium (177Lu) vipivotide tetraxetan
- Lutetium 177-labelled radiohybrid prostate-specific membrane antigen-10.1 ((177Lu) rhPSMA-10.1)
- lutikizumab
- lutropin alfa
- lysine
- Lysine acetate
- lysine acetylsalicylate
- lysine L
- lysine monohydrate
- macimorelin
- macimorelin acetate
- macitentan
- Macrogol 3350
- macrogol 4000
- macrogol 4000 combinations
- MAGE-A3 recombinant protein
- magnesium acetate
- magnesium acetate tetrahydrate
- magnesium aspartate
- magnesium chloride
- magnesium chloride hexahydrate
- magnesium hydroxide
- Magnesium lactate dihydrate Tramadol (hydrochloride)
- magnesium sulfate
- magnesium sulfate heptahydrate
- magnesium sulfate heptahydrate (BLI800)
- Magrolimab
- Malic acid
- mangafodipir
- mangafodipir trisodium
- Manganese chloride tetrahydrate
- manidipine
- manidipine, delapril
- Mannheimia haemolytica biotype A serotype A1, inactivated cell free suspension containing leukotoxoid Ph. Eur.
- mannitol
- mannose-1-phosphate (GLM101)
- maplirpacept
- maralixibat
- Maralixibat chloride
- maralixibat chloride
- maraviroc
- marbofloxacin
- Marek's disease vaccine (live recombinant)
- Marek's disease vaccine, Newcastle disease vaccine & infectious laryngotracheitis vaccine (live recombinant)
- Marek’s disease virus, strain RN1250, live
- Maribavir
- maribavir
- Marizomib
- maropitant
- maropitant citrate
- Maropitant citrate monohydrate
- marstacimab
- Marzeptacog alfa (activated)
- masitinib
- Masitinib mesilate
- masitinib mesilate
- matricaria recutita L., flos
- matrix-applied characterised autologous cultured chondrocytes
- Matrix applied characterised autologous cultured chondrocytes
- matrix applied characterised autologous cultured chondrocytes
- Mavacamten
- mavacamten
- mavacoxib
- mavodelpar
- Mavorixafor
- Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063.
- mazindol
- measles, mumps, rubella and varicella vaccine (live)
- measles, mumps and rubella vaccine (live)
- measles vaccine (live attenuated)
- measles virus Enders’ Edmonston strain (live, attenuated)
- Measles virus Schwarz strain (live, attenuated)
- Mecasermin
- mecasermin
- Mecasermin rinfabate
- mecasermin rinfabate
- medetomidine
- medetomidine hydrochloride
- Medium-chain triglycerides
- medroxyprogesterone acetate
- mefenorex
- mefloquine
- melatonin
- Meldonium dihydrate
- melissa officinalis L., folium
- melitracene
- meloxicam
- melphalan
- melphalan flufenamide
- Melphalan flufenamide hydrochloride
- melphalan hydrochloride
- memantine
- memantine hydrochloride
- meningococcal group A, C, W-135 and Y conjugate vaccine
- meningococcal group a and c polysaccharide vaccine
- Meningococcal group A oligosaccharide conjugated to Corynebacterium diphteriae CRM197 protein (MenA-CRM) Meningococcal group C oligosaccharide conjugated to Corynebacterium diphteriae CRM197 protein (MenC-CRM) Meningococcal group W-135 oligosaccharide conjugated to Corynebacterium diphteriae CRM197 protein (MenW-CRM) Meningococcal group Y oligosaccharide conjugated to Corynebacterium diphteriae CRM197 protein (MenY-CRM)
- meningococcal group A oligosaccharides conjugated to corynebacterium diphtheriae CRM197 protein
- meningococcal group B Vaccine (rDNA, component, adsorbed)
- meningococcal group b vaccine (recombinant, adsorbed)
- meningococcal group c conjugate vaccine
- meningococcal group C oligosaccharides conjugated to corynebacterium diphtheriae CRM197 protein
- meningococcal group c polysaccharide conjugate vaccine
- meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed)
- meningococcal groups A, C, W-135 and Y conjugate vaccine
- meningococcal group W-135 oligosaccharides conjugated to corynebacterium diphtheriae CRM197 protein
- meningococcal group Y oligosaccharides conjugated to corynebacterium diphtheriae CRM197 protein (MenABCWY)
- menotrophin
- Menotropin
- menotropin
- mentha piperita L., folium
- menthol
- mepivacaine
- mepivacaine hydrochloride
- Mepolizumab
- mepolizumab
- meprobamate
- mequitazine
- mercaptamine
- mercaptamine bitartrate
- mercaptamine hydrochloride
- mercaptopurine
- Mercaptopurine monohydrate
- Meropenem
- meropenem
- meropenem trihydrate
- Mesalazine
- Messenger RNA encoding Cas9 and single guide RNA targeting the human TTR gene
- messenger RNA encoding Cas9, single guide RNA targeting the human KLKB1 gene
- mesterolone
- metaflumizone
- metamizole
- metamizole sodium
- metamizol sodium
- Metformin
- metformin
- metformin hydrochloride
- methacetin (13C)
- methacholine
- Methacholine chloride
- methadone
- methionine
- methocarbamol
- methohexital
- methotrexate
- Methoxyflurane
- Methoxy polyethylene glycol-epoetin beta
- methoxy polyethylene glycol-epoetin beta
- Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate mono(4-methylbenzenesulfonate)
- methylaminolevulinate
- Methyl aminolevulinate hydrochloride
- methylnaltrexone bromide
- methylphenidate
- Methylphenidate (hydrochloride)
- methylphenidate hydrochloride
- methylphenobarbital
- methylprednisolone
- methylprednisolone acetate
- methylprednisolone hydrogen succinate
- methyl salicylate
- methylthioninium chloride
- methysergide
- metoclopramide
- metoclopramide hydrochloride
- metoprolol
- metoprolol (tartrate)
- Metreleptin
- metreleptin
- Metronidazole
- Metronidazole (benzoate)
- metyrapone
- mexazolam
- mexiletine hcl
- Mexiletine hydrochloride
- mezagitamab
- mianserine
- micafungin
- Miconazole
- miconazole nitrate
- midazolam
- Midazolam Hydrochloride
- midodrine
- Midostaurin
- midostaurin
- mifamurtide
- mifepristone
- migalastat
- migalastat hydrochloride
- Miglitol
- miglustat
- MIJ821
- milbemycin oxime
- milnacipran
- milrinone
- milvexian
- minocycline
- minoxidil
- mipomersen sodium
- Mirabegron
- mirabegron
- mirdametinib
- Miridesap
- Mirikizumab
- mirikizumab
- mirtazapine
- mirvetuximab soravtansine
- mirvetuximab soravtansine
- misoprostol
- misoprostol (gastrointestinal indication)
- misoprostol (gynaecological indication - termination of pregnancy)
- Mitapivat
- mitapivat
- mitapivat sulfate
- Mitotane
- mitotane
- mitoxantrone
- mitratapide
- mivacurium
- mixture of 2 synthetic double-stranded N-Acetyl-galactosamine conjugated siRNA oligonucleotides that are directed against hepatitis B virus (JNJ-73763989)
- mixture of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis (Grasses-Mix) and Secale cereale (50/50) allergen extracts
- mixture of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis (Grasses-Mix) and Secale cereale (75/25) allergen extracts
- mixture of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis allergen extracts
- mixture of Phleum pratense and Secale cereale allergen extracts
- mizalostine
- mizolastine
- mobocertinib
- moclobemide
- Mocravimod
- modafinil
- Modakafusp Alfa
- modified, recombinant version of the human myeloid-derived growth factor
- Modified allergen extract of birch pollen
- Modified allergen extract of pollen from Phleum pratense
- Modified human papillomavirus capsid protein conjugated to the near-infrared dye silicate(5-),bis[N-[3- [(hydroxy-.kappa.O)dimethylsilyl]propyl]-3-sulfo-N,N-bis(3-sulfopropyl)-1-propanaminiumato(4-)][6- [[[3-[(29H,31H-phthalocyanin-yl-.kappa.N29,.kappa.N30,.kappa.N31,.kappa.N32)oxy]propoxy] carbonyl]amino]hexanoato(3-)]-, sodium (1:5)
- modified live bovine viral diarrhoea virus type 1, non-cytopathic parent strain KE-9 and modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
- Modified live porcine respiratory and reproductive syndrome virus
- modified messenger ribonucleic acid encoding human propionyl-coenzyme a carboxylase alpha and beta subunits encapsulated into lipid nanoparticles (mRNA-3927)
- modified messenger ribonucleic acid encoding individual patient-specific tumour neoantigens (V940/ mRNA-4157)
- modified mRNA encoding human methylmalonyl-coenzyme A mutase containing a polymorphism at position 671 (mRNA-3705)
- modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus
- Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox)
- modRNA encoding 4 influenza HA antigens (2 for influenza A and 2 for influenza B strains) (qIRV)
- moexipril
- Mogamulizumab
- mogamulizumab
- Molgramostim
- Molibresib
- Molidustat (sodium)
- Molnupiravir
- molnupiravir
- Momelotinib
- momelotinib
- Momelotinib dihydrochloride monohydrate
- mometasone
- Mometasone (furoate)
- Mometasone (furoate monohydrate)
- Mometasone furoate
- mometasone furoate
- Monalizumab
- monensin
- monensin (as monensin sodium)
- monepantel
- Monoclonal IgG1 anti-influenza A antibody
- Monovalent, live, recombinant, replication-incompetent adenoviral serotype 26 vectored vaccine expressing the full length glycoprotein of the Ebola virus Mayinga variant [Ad26.ZEBOV]
- Monovalent, recombinant, replication-incompetent human adenovirus serotype 26-vectored vaccine encoding the pre-fusion conformation-stabilised F protein derived from the RSV A2 strain
- monovalent and multivalent measles, mumps, rubella and varicella vaccines (live)
- montelukast
- Montelukast sodium
- moraxella catarrhalis
- moroctocog alfa
- morphine
- Morphine (hydrochloride)
- morphine sulphate
- Mosunetuzumab
- mosunetuzumab
- Motavizumab
- motugivatrep
- Moxetumomab pasudotox
- moxetumomab pasudotox
- moxidectin
- moxifloxacin
- Moxifloxacin hydrochloride
- moxonidine
- Mozafancogene autotemcel
- mozafancogene autotemcel
- mRNA encoding for the linked NTD and RBD domains of the spike glycoprotein of SARS-CoV-2 (mRNA-1283)
- mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein, mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein, mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein, mRNA-1283
- mRNA encoding modified human ornithine transcarbamylase (ARCT-810)
- mugwort pollen
- Multivalent, live, recombinant, non-replicating in human cells, Modified Vaccinia Ankara vectored vaccine, expressing the EBOV Mayinga glycoprotein, the Sudan virus Gulu GP, the Marburg virus Musoke GP, and the Taï Forest virus nucleoprotein [MVA-BN-Filo]
- Multivalent pneumococcal polysaccharide conjugate to carrier protein (PCV21)
- mumps virus Jeryl Lynn (level B) strain (live, attenuated)
- Mumps virus RIT 4385 strain, derived from Jeryl Lynn strain (live, attenuated)
- mupirocin
- MVA-BN-RSV vaccine (construct MVA-mBN294B)
- Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10)
- Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10)
- mycophenolate mofetil
- mycophenolic acid
- mycoplasma hyopneumoniae, strain 2940, inactivated
- Mycoplasma hyopneumoniae, strain 7304 (Nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated
- Mycoplasma hyopneumoniae, strain J, inactivated
- Mycoplasma hyopneumoniae and porcine circovirus vaccine (inactivated, recombinant)
- mycoplasma hyopneumoniae vaccine (inactivated)
- Mycoplasma synoviae (live)
- Mycoplasma synoviae, strain K588A, Live
- Mycoplasma synoviae strain MS-H
- myristalkonium, benzalkonium (vaginal use only)
- myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant)
- N(2)-L-alanyl-L-glutamine
- N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)- 6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate
- N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[(2S)-1,1,1-trifluoro-2-propanyl]sulfamoyl]-1H-pyrrole-2- carboxamide (JNJ-56136379)
- N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2- yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d] pyrimidin-6-yl)phenyl)methacrylamide (hydrochloride) (RLY-4008)
- N-(6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide (RIST-4721)
- N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl) cyclobutyl)-3-phenylisoxazole-5-
- n-acetyl-histidine (monohydrate)
- N-Acetyl-L-Cysteine (corresponds to L-Cysteine), L-Alanine, L-Alanyl-L-Glutamine (corresponds to L-Alanine and L-Glutamine), L-Arginine, Glycine, Glycyl-L-Tyrosine (corresponds to Glycine and L-Tyrosine), L-Histidine, L-Isoleucine, L-Leucine, L-Lysine acetate (corresponds to L-Lysine), LMethionine, L-Phenylalanine, L-Proline, L-Serine, Taurine, L-Threonine, L-Tryptophan, L-Valine
- N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl) pyridin-2-yl) acetamide (KX2-391)
- N-hydroxy-5-methylfuran-2-sulfonamide (BMS-986231)
- N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide dihydrochloride monohydrate (SAR302503A)
- N-[(1R)-1-(1H-indol-3-ylmethyl)pentyl]-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide (UCB0599)
- N-[4-(3-amino-1H-indazol-4 yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea (ABT-869)
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide
- N-{2-(2,3-Difluorobenzylthio)-6-[(2R,3S)-3,4-dihydroxybut-2-yloxy]pyrimidin-4-yl}azetidine-1-sulfonamide (AZD5069)
- N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl) benzenesulfonamide, sodium salt
- N. meningitidis serogroup C polysaccharide conjugated to tetanus toxoid
- N. meningitidis serogroup W polysaccharide conjugated to tetanus toxoid (MenACYW)
- N. meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid
- N2’-Deacetyl-N2’-[4-methyl-4-(oxobutyldithio)-1-oxopentyl]-maytansine-hu769_4D4 Antibody
- Nabilone
- nabumetone
- nadifloxacin
- Nadofaragene firadenovec
- nadroparin
- nafarelin
- naftidrofuryl
- naftifine
- nalbuphine
- Naldemedine
- naldemedine
- Naldemedine tosilate
- Nalfurafine hydrochloride
- nalidixic acid
- nalmefene
- Nalmefene hydrochloride dihydrate
- Naloxegol
- naloxegol
- naloxegol oxalate
- naloxone
- naloxone (hydrochloride)
- naloxone hydrochloride
- Naloxone hydrochloride dihydrate
- Naltrexone
- naltrexone
- naltrexone hydrochloride
- namilumab
- Nanobody directed towards the fusion protein of human respiratory syncytial virus (ALX-0171)
- naphazoline
- naproxcinod
- naproxen
- naproxen (sodium)
- naratriptan
- Narsoplimab
- natalizumab (1)
- natamycin
- nateglinide
- navepegritide
- navitoclax
- nebivolol
- nebivolol (hydrochloride)
- necitumumab
- Nedosiran
- nefopam
- nefopam (hydrochloride)
- Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid carrier protein (MenABCWY)
- Neisseria meningitidis group B fHBP protein subfamily A
- Neisseria meningitidis group B fHBP protein subfamily B
- Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid carrier protein
- Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid carrier protein
- Neisseria meningitidis group W polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid carrier protein
- Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid
- Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B
- Neisseria meningitidis serogroup B fHbp subfamily A
- Neisseria meningitidis serogroup B fHbp subfamily B
- Neisseria meningitidis serogroup B Protein-based active substance
- Neisseria meningitidis serogroup B Protein-based active substance (MenPenta vaccine)
- Neisseria meningitidis serogroup B recombinant lipoprotein (rLP2086; subfamily A; Escherichia coli)
- Neisseria meningitidis serogroup B recombinant lipoprotein (rLP2086; subfamily B; Escherichia coli)
- nelarabine
- nelfinavir
- nemolizumab
- Nemtabrutinib
- nemvaleukin alfa
- neomycin
- neomycin sulfate
- neonatal piglet colibacillosis (recombinant, inactivated)
- neonatal piglet colibacillosis vaccine (inactivated)
- neonatal piglet colibacillosis vaccine (recombinant, inactivated)
- neostigmine
- nepafenac
- neratinib
- neridronic acid
- Netarsudil
- netarsudil
- Netarsudil mesilate
- netilmicin
- netupitant
- nevirapine
- Newcastle disease
- Newcastle disease and Marek’s disease vaccine (live recombinant)
- Newcastle disease virus, strain Clone, live attenuated
- Newcastle disease virus, strain clone, live attenuated
- Newcastle disease virus, strain Ulster, inactivated
- Newcastle disease virus, VG/GA strain, live
- Newcastle disease virus vaccine (inactivated)
- niaouli
- nicardipine
- nicergoline
- niclosamide
- nicoboxil
- nicorandil
- nicotine
- nicotinic acid
- Nifedipine
- nifedipine
- niflumic
- niflumic acid
- nifuroxazide
- nifurtimox
- nifurtoinol
- nilotinib
- nilutamide
- nimesulide
- nimesulide (systemic formulations)
- nimesulide (topical formulations)
- Nimodipine
- nimotuzumab
- nintedanib
- Nipocalimab
- nipocalimab
- niraparib
- niraparib (tosilate monohydrate)
- nirmatrelvir
- nirmatrelvir / ritonavir
- nirogacestat
- nirogacestat hydrobromide
- Nirsevimab
- nirsevimab
- nitisinone
- nitrazepam
- nitrendipine
- Nitric oxide
- nitric oxide
- nitrofurantoin
- nitrosomonas eutropha, strain D23, live
- nitrous oxide
- nitroxinil
- Nivolumab
- nivolumab
- nizaracianine triflutate
- Nomegestrol
- nomegestrol
- Nomegestrol acetate
- nomegestrol acetate
- Non-pathogenic bacterial lysate of Escherichia coli and Enterococcus faecalis
- Nonacog alfa
- nonacog alfa
- Nonacog beta pegol
- nonacog beta pegol
- Nonacog gamma
- nonacog gamma
- nonivamide
- norelgestromin
- norepinephrine
- norethisterone
- norethisterone acetate
- norfloxacin
- norgestimate
- Norovirus GI.1 virus-like particle antigen
- norovirus GII.4 virus-like particle antigen
- norpseudoephedrine
- nortriptyline
- Norursodeoxycholic acid
- Nusinersen
- nusinersen
- nusinersen sodium
- nystatin
- nyxthracis
- Obecabtagene autoleucel
- obecabtagene autoleucel
- Obefazimod
- obeldesivir
- Obeticholic acid
- obeticholic acid
- Obicetrapib
- obicetrapib
- Obidoxime (chloride)
- Obiltoxaximab
- obiltoxaximab
- Obinutuzumab
- obinutuzumab
- oblimersen
- ociperlimab
- oclacitinib maleate
- ocrelizumab
- ocreotide
- ocriplasmin
- octenidine
- octenidine dihydrochloride
- Octocog alfa
- octocog alfa
- octreotide
- Octreotide acetate
- octreotide hydrochloride
- Odanacatib
- odevixibat
- odevixibat sesquihydrate
- Odronextamab
- odronextamab
- oestrogens conjugated
- Ofatumumab
- ofatumumab
- ofloxacin
- ofloxacin (systemic use)
- Ofloxacin (topical use)
- Ofranergene obadenovec
- olanzapine
- olanzapine pamoate
- olanzapine pamoate monohydrate
- Olaparib
- olaparib
- Olaratumab
- olaratumab
- oleclumab
- Olenasufligene relduparvovec
- Olesoxime
- olezarsen
- olezarsen sodium
- Olinciguat
- Olipudase alfa
- olipudase alfa
- olive oil
- olmesartan
- Olmesartan medoxomil
- olodaterol
- Olodaterol (hydrochloride)
- Olokizumab
- olopatadine
- Olopatadine (hydrochloride) (GSP 301 NS)
- olopatadine hydrochloride
- Olpasiran
- olsalazine
- Olutasidenib
- omacetaxine mepesuccinate
- Omadacycline
- omalizumab (1)
- Omaveloxolone
- omaveloxolone
- Ombitasvir
- ombitasvir
- Ombrabulin
- Omecamtiv mecarbil
- omecamtiv mecarbil
- Omecamtiv mecarbil dihydrochloride hydrate
- Omega-3 fatty acid ethyl esters
- omega-3 fatty acid ethyl esters
- Omega-3-acid (85% ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a ratio of 0.9-1.5)
- omega-3-acid-ethyl esters
- omega-3-acid ethyl esters 90
- Omega-3-carboxylic acids
- omeprazole
- Onasemnogene abeparvovec
- onasemnogene abeparvovec
- ondansetron
- Ondansetron (hydrochloride)
- One of the following inactivated bluetongue virus strains:Inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
- onfekafusp alfa
- ontasameran
- opicapone
- Opicinumab
- opium
- Oportuzumab monatox
- oportuzumab monatox
- orbifloxacin
- Oregovomab
- Orforglipron
- oritavancin
- oritavancin (diphosphate)
- orlistat
- ornithine
- ornithine hydrochloride
- orphenadrine (citrate)
- orthophenylphenol
- Orvepitant
- osaterone acetate
- oseltamivir
- Oseltamivir (phosphate)
- osilodrostat
- Osilodrostat phosphate
- osimertinib
- Osimertinib (as mesilate)
- osimertinib mesilate
- osivelotor
- ospemifene
- Otenaproxesul
- oteracil
- Oteseconazole
- oteseconazole
- outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B)
- outer membrane vesicles (OMV) from n. meningitidis strain NZ 98/254
- Outer Membrane Vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4
- outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254)
- oxalic acid dehydrate
- oxalic acid dihydrate
- oxalic acid dihydrate / formic acid
- oxaliplatin
- Oxalobacter formigenes strain HC-1
- oxatomide
- oxcarbazepine
- oxolinic acid
- oxybutynin
- oxyclozanide
- oxycodone
- Oxycodone (hydrochloride)
- oxycodone hydrochloride
- oxygen
- oxymetazoline
- Oxymetazoline hydrochloride
- oxytetracycline hydrochloride
- Oxytocin
- oxytocin (systemic use)
- ozanimod
- Ozanimod (hydrochloride)
- ozanimod hydrochloride
- Ozenoxacin
- pabinafusp alfa
- paclitaxel
- Pacritinib
- padeliporfin
- padeliporfin di-potassium
- Pagibaximab
- Palbociclib
- palbociclib
- palifermin
- paliperidone
- paliperidone palmitate
- palivizumab
- palmitic acid
- Palmitoyl-KSS-ELQTTIHDIILECVYCKQQLL (HPV-16 E6 25-45) + [(2R)-2,3-bis[[(Z)-octadec-9- enoyl]oxy]propyl]-trimethylazanium chloride (R-DOTAP chloride)
- Palmitoyl-KSS-GQAEPDRAHYNIVTF (HPV-16 E7 43-57)
- Palmitoyl-KSS-LLMGTLGIV (HPV-16 E7 82-90)
- Palmitoyl-KSS-MHGDTPTLHEYMLDLQPETT (HPV-16 E7 1-20)
- Palmitoyl-KSS-YMLDLQPETT (HPV-16 E7 11-20)
- Palmitoyl-KSSKKLLMGTLGIVCPICSQKP (HPV-16 E7 82-98)
- palmitoyl-oleoyl phosphatidylglycerol
- Palonosetron
- palonosetron
- palonosetron hydrochloride
- palopegteriparatide
- Palovarotene
- palovarotene
- pamidronate
- pamidronic acid
- Pamiparib
- Pamrevlumab
- pancreas powder
- pancrelipase
- pancuronium
- pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted)
- Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted), containing antigen equivalent to Influenza A/California/7/2009
- pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
- pandemic influenza vaccine (H5N1) (live attenuated, nasal)
- pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
- pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)
- pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
- Pandemic live attenuated influenza virus (H5N1)
- panitumumab
- panobinostat
- Panobinostat as panobinostat lactate salt
- panobinostat lactate anhydrous
- pantoprazole
- Para-aminosalicylic acid
- para-aminosalicylic acid
- Paracetamol
- paracetamol
- paracetamol (IV formulation)
- Paraffin liquid
- parathyroid hormone
- parathyroid hormone (rDNA)
- parecoxib
- parecoxib sodium
- paricalcitol
- paritaprevir
- paromycin
- paroxetine
- Parsaclisib
- parsaclisib
- Parsaclisib (as hydrochloride)
- Parsaclisib (hydrochloride)
- Parsaclisib hydrochloride
- pasireotide
- patent blue V sodium
- Patidegib
- patiromer
- patiromer sorbitex calcium
- patisiran
- patisiran sodium
- Patritumab deruxtecan
- Patupilone
- Paullinia cupana Kunth
- pazopanib
- peanut allergen extract
- peanut flour
- pefloxacin
- pegaptanib
- Pegaptanib sodium
- pegaspargase
- Pegbovigrastim
- pegbovigrastim
- pegcetacoplan
- pegfilgrastim (16)
- peginesatide
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- Peginterferon lambda-1a
- pegloticase
- Pegunigalsidase alfa
- pegunigalsidase alfa
- Pegvaliase
- pegvaliase
- Pegvisomant
- pegvisomant
- pegvorhyaluronidase alpha
- pegylated-fibroblast growth factor 21 (BMS-986036)
- pegylated proline-interferon alpha-2b
- pegylated recombinant factor VIIa
- Pegzilarginase
- pegzilarginase
- pelargonium reniforme curt. / radix
- pelargonium sidoides dc
- pelargonium sidoides dc and-or pelargonium reniforme curt-radix
- Pemafibrate
- pembrolizumab
- pemetrexed
- pemetrexed diacid monohydrate
- pemetrexed disodium
- pemetrexed disodium hemipentahydrate
- pemetrexed disodium heptahydrate
- pemetrexed ditromethamine
- pemigatinib
- penciclovir
- pentamidine
- pentosan polysulfate sodium
- pentoxyverine
- peppermint oil
- Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain (BI 456906)
- Peptide KLBPVQLWV / Peptide SMPPPGTRV / Peptide YLQLVFGIEV / Peptide RLLQETELV / Peptide YLSGADLNL / Peptide LLTFWNPPV / Peptide IMIGHLVGV / Peptide KVAEIVHFL / Peptide KVFGSLAFV / Pan HLA DR-binding epitope D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala (OSE2101)
- Peramivir
- peramivir
- perampanel
- Perflubutane
- perflutren
- pergolide
- perindopril
- perindopril (tosilate)
- perindopril arginine
- perindopril erbumine
- perindopril tert-butylamine
- permethrin
- perphenazine
- pertactin
- pertussis
- pertussis (acellular, component)
- pertussis (acellular, component) vaccine (adsorbed), diphtheria
- pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents
- pertussis filamentous haemagglutinin
- pertussis filamentous haemagglutinin (FHA)
- pertussis haemagglutin filamentous
- pertussis pertactin
- pertussis toxin
- pertussis toxoid
- pertuzumab
- pethidine
- petosemtamab
- Pevonedistat
- Pexastimogene devacirepvec
- Pexidartinib
- pexidartinib
- Pexiganan (acetate)
- phenazone
- phendimetrazine
- pheniramine maleate
- phenmetrazine
- Phenobarbital
- phenobarbital
- phenol
- phenoxyethanol
- phenoxymethylpenicillin
- phentermine
- phentolamine mesilate
- Phenyl- and piperidin-containing derivative of amiloride (BI 443651)
- phenylalanine
- phenylalanine L
- phenylephrine
- phenylephrine (ophthalmic formulations)
- phenylephrine hydrochloride
- phenylpropanolamine
- phenytoin
- Phleum pratense
- Phleum pratense allergen extract
- Phleum pratense L.
- phloroglucinol
- phloroglucinol / trimethylphloroglucinol
- phloroglucinol trimethylphloroglucinol
- Pholcodine
- pholcodine
- phosphocreatine
- Phospholipid esters from herring roe (HRO350)
- physostigmine
- pibrentasvir
- Piflufolastat (18F)
- piflufolastat (18F)
- pilocarpine
- Pilocarpine (hydrochloride)
- Pimavanserin
- pimecrolimus
- pimobendan
- Pimodivir
- pimozide
- pioglitazone
- pioglitazone hydrochloride
- pipemidic acid
- piperacillin
- piperaquine phosphate anhydride
- piperaquine tetraphosphate
- pipobroman
- piracetam
- pirenoxine
- piretanide
- Pirfenidone
- pirfenidone
- piribedil
- pirlimycin
- piroxicam
- pirtobrutinib
- pitavastatin
- pitavastatin (calcium)
- pitofenone hydrochloride
- pitolisant
- pixantrone dimaleate
- plasma fibronectin
- plasma protein fraction
- plasminogen
- Plasmodium falciparum and hepatitis B vaccine (recombinant, adjuvanted)
- Plazomicin (sulfate)
- Plerixafor
- plerixafor
- plinabulin
- plitidepsin
- pneumococcal oligosaccharide serotype 18C
- pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)
- Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)
- Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
- pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
- pneumococcal polysaccharide conjugate vaccine (21-valent)
- pneumococcal polysaccharide conjugate vaccine (adsorbed)
- Pneumococcal polysaccharide serotype 1
- Pneumococcal polysaccharide serotype 1 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein
- pneumococcal polysaccharide serotype 1- diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 3
- pneumococcal polysaccharide serotype 3 - diphtheria CRM197 conjugate
- pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein
- Pneumococcal polysaccharide serotype 4
- pneumococcal polysaccharide serotype 4 - diphtheria CRM197 conjugate
- pneumococcal polysaccharide serotype 4 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein
- Pneumococcal polysaccharide serotype 5
- pneumococcal polysaccharide serotype 5 - diphtheria CRM197 conjugate
- pneumococcal polysaccharide serotype 5 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein...
- Pneumococcal polysaccharide serotype 6A
- pneumococcal polysaccharide serotype 6A- diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 6B
- pneumococcal polysaccharide serotype 6B - diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 7F
- pneumococcal polysaccharide serotype 7F - diphtheria CRM197 conjugate
- Pneumococcal Polysaccharide Serotype 8
- Pneumococcal polysaccharide serotype 8
- Pneumococcal Polysaccharide Serotype 9N
- Pneumococcal polysaccharide serotype 9V
- pneumococcal polysaccharide serotype 9V - diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 10A
- Pneumococcal polysaccharide serotype 11A
- pneumococcal polysaccharide serotype 12F
- Pneumococcal polysaccharide serotype 14
- pneumococcal polysaccharide serotype 14 - diphtheria CRM197 conjugate
- Pneumococcal Polysaccharide Serotype 15A
- Pneumococcal polysaccharide serotype 15b
- Pneumococcal Polysaccharide Serotype 15C
- Pneumococcal Polysaccharide Serotype 16F
- Pneumococcal Polysaccharide Serotype 17F
- Pneumococcal polysaccharide serotype 18C
- pneumococcal polysaccharide serotype 18C - diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 19A
- pneumococcal polysaccharide serotype 19A - diphtheria CRM197 conjugate
- Pneumococcal polysaccharide serotype 19F
- pneumococcal polysaccharide serotype 19F - diphtheria CRM197 conjugate
- Pneumococcal Polysaccharide Serotype 20
- Pneumococcal Polysaccharide Serotype 22F
- Pneumococcal polysaccharide serotype 22F
- pneumococcal polysaccharide serotype 22F - diphtheria CRM197 conjugate
- Pneumococcal Polysaccharide Serotype 23A
- Pneumococcal Polysaccharide Serotype 23B
- Pneumococcal polysaccharide serotype 23F
- pneumococcal polysaccharide serotype 23F - diphtheria CRM197 conjugate
- Pneumococcal Polysaccharide Serotype 24F
- Pneumococcal Polysaccharide Serotype 31
- Pneumococcal polysaccharide serotype 33F
- pneumococcal polysaccharide serotype 33F – diphtheria CRM197 conjugate (15-valent pneumococcal polysaccharide conjugate vaccine [V114])
- Pneumococcal Polysaccharide Serotype 35B
- Pneumococcal polysaccharides individually biotinylated and complexed with a carrier protein (recombinant fusion construct of rhizavidin and Streptococcus pneumoniae derived proteins), 24-valent
- pneumococcal saccharide conjugated vaccine, adsorbed
- Poa pratensis
- Poa pratensis L.
- podophyllotoxin
- polatuzumab vedotin
- Polihexanide
- polihexanide
- poliomyelitis
- poliomyelitis (inactivated)
- poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)
- poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain))
- poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain))
- poliovirus (inactivated): type 1 (Mahoney), type 2 (MEF-1), type 3 (Saukett) produced in Vero cells/ Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein.
- poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett)
- poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells
- poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells
- poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells
- poliovirus type 1
- poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine
- poliovirus type 1 vaccine
- poliovirus type 2
- poliovirus type 2 vaccine
- poliovirus type 3
- poliovirus type 3 (oral, live, attenuated) vaccine
- poliovirus type 3 vaccine
- pollen from Alnus glutinosa, Betula verrucosa and Corylus avellana
- pollen from Dactylis glomarata (8%), Lolium perenne (8%), Phleum pratense (8%), Poa pratensis (8%), Anthoxhantum odoratum (8%), Secale cereale (10%), Betula pendula (16.7%), Corylus avellana (16.6%) and Alnus glutinosa (16.6%)
- Pollen from Dactylis glomarata (16%), Festuca pratensis (16%), Lolium perenne (16%), Phleum pratense (16%), Poa pratensis (16%), Secale cereale (20%)
- Pollen from Dactylis glomarata (16%), Lolium perenne (16%), Phleum pratense (16%), Poa pratensis (16%), Anthoxhantum odoratum (16 %) and Secale cereale (20%)
- Pollen from Dactylis glomarata, Lolium perenne, Phleum pratense, Poa pratensis and Anthoxhantum odoratum (20% each)
- pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale, Betula verrucosa, Corylus avellana and Alnus glutinosa
- Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris
- Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Secale cereale (20% each)
- Pollen from Dactylis glomerata, Lolium perenne, Phleum pratense, Festuca pratensis, Secale cereale
- Pollen from Phleum pratense
- poly (o-2-hydroxyethyl) starch
- Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) (TransCon PTH)
- polyethylene glycol 3350
- polygala syrup
- Polymyxin B
- polymyxin b sulfate
- polyribosylribitol phosphate (PRP) from Haemophilus influenzae type b as prp-ompc
- polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC
- polystyrene sulfonate
- Pomalidomide
- pomalidomide
- Ponatinib
- ponatinib
- ponesimod
- porcine circovirus 2, ORF2 capsid protein
- porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)
- porcine circovirus recombinant virus (CPCV) 1-2, inactivated
- Porcine circovirus type 2 (PCV2) ORF2 subunit antigen, Mycoplasma hyopneumoniae J strain inactivated
- porcine circovirus type 2 ORF2 protein
- porcine circovirus type 2 ORF2 subunit antigen
- porcine circovirus type 2, ORF2 capsid protein
- porcine circovirus vaccine (inactivated)
- porcine circovirus vaccine (inactivated, recombinant)
- porcine circovirus vaccine (inactivated recombinant)
- porcine influenza vaccine (inactivated)
- porcine pancreas enzymes
- porcine parvovirosis vaccine (inactivated)
- Porcine parvovirus, strain 27a, viral protein 2
- porcine parvovirus, strain NADL-2 and Erysipelothrix rhusiopathiae, strain R32E11 (inactivated)
- porcine parvovirus and Erysipelothrix rhusiopathiae
- porcine post-weaning diarrhoea vaccine (live)
- porcine respiratory and reproductive syndrome virus, live
- porcine respiratory and reproductive syndrome virus vaccine (live)
- porfimer
- porfimer sodium
- posaconazole
- Posoleucel
- potassium acetate
- potassium bitartrate
- potassium chloride
- potassium chloride (NER1006)
- potassium citrate
- potassium citrate monohydrated
- potassium clavulanate
- potassium hydrogen carbonate
- potassium hydrogen carbonate (ADV7103)
- potassium para-aminobenzoate
- potassium para aminobenzoate
- potassium salts
- potassium sulfate
- povidone
- povidone iodinated
- povorcitinib
- pozelimab
- pracinostat
- pradigastat
- pradofloxacin
- pralatrexate
- pralsetinib
- pramipexole
- pramipexole dihydrochloride monohydrate
- pramiracetam
- prasterone
- prasugrel
- prasugrel (hydrochloride)
- prasugrel besilate
- pravastatin
- Pravastatin sodium
- praziquantel
- prednicarbate
- Prednisolone
- prednisolone
- prednisolone metasulphobenzoate
- prednisolone sodium phosphate
- pregabalin
- prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture)
- pretomanid
- pridopidine
- pridopidine hydrochloride
- prilocaine
- primidone
- pritelivir (mesylate monohydrate)
- procaine (hydrochloride)
- processed nerve allograft (human)
- procyanidolic oligomers
- progesterone
- proguanil
- proguanil hydrochloride
- prolgolimab
- proline
- promestriene
- promethazine
- promethazine hydrochloride
- propafenone
- propan-2-yl 2-[5-( acryloylamino )-4-{ [2-( dimethylamino )ethyl] ( methyl)amino }-2-methoxyanilino ]-4- ( 1 methyl-1 H-indol-3-yl)pyrimidine-5-carboxylate
- propofol
- propranolol
- propranolol (except for centrally authorised product)
- propranolol hydrochloride
- propylene glycol
- propylhexedrine
- proteinase, metallo- (synthetic nociceptin receptor-binding) 1290102-81-6 (AGN214868)
- protein dO (non-toxic deletion derivative of Pasteurella multocida dermonecrotic toxin)
- proteolytic enzymes enriched in bromelain
- protirelin
- prucalopride
- prucalopride succinate
- prulifloxacin
- pseudoephedrine
- pseudoephedrine hydrocholoride
- pseudophedrine sulfate
- pudexacianinium chloride
- pUK-SPDV-poly2#1 DNA plasmid coding for salmon pancreas disease virus proteins
- purified adenylate cyclase recombinant protein carrying subfragments of the early protein E7 antigen from human papillomavirus strain 16 (recombinant CyaA-HPV16E7)
- purified adenylate cyclase recombinant protein carrying subfragments of the early protein E7 antigen from human papillomavirus strain 18 (recombinant CyaA-HPV18E7)
- purified antigen fractions of inactivated split virion Influenza A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)
- purified antigen fractions of inactivated split virion Influenza A/Indonesia/5/05 (H5N1)
- purified antigen fractions of inactivated split virion Influenza A/Vietnam/1194/2004 (H5N1) like strain used (NIBRG-14)
- purified antigen fractions of inactivated split virion influenza virus type A, H1N1
- purified diphtheria toxoid
- purified diphtheria toxoid (DTaP-IPV-HepB-PRP-T)
- purified egg phosphatide
- purified filamentous haemagglutinin
- purified fimbriae types 2 and 3
- purified inactivated rabies virus (WISTAR PM/WI 38-1503-3M strain)
- purified p45 feline leukaemia virus envelope antigen
- purified p45 FeLV-envelope antigen
- purified pertactin
- purified pertussis filamentous haemagglutinin
- purified pertussis toxoid
- purified polyribosylribitol phosphate capsular polysaccharide of Haemophilus influenzae type b covalently bound to Tetanus protein (PRP-T)
- purified Rp-45 FeLV-envelope antigen
- purified tetanus toxoid
- pyrantel
- pyrantel embonate
- pyridine-3-carboxamide derivative (K-161)
- pyridoxine
- pyridoxine (hydrochloride)
- pyrimidinyl-aminopyridine dual leucine zipper kinase inhibitor (GDC-0134)
- pyriprole
- pyriproxyfen
- pyronaridine
- quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18)
- quadrivalent influenza vaccine (recombinant, prepared in cell culture)
- quavonlimab
- quetiapine
- quilizumab
- quinagolide
- quinapril
- quinidine
- quinidine sulfate
- quinine
- quizartinib
- quizartinib dihydrochloride
- rAAV8 viral vector encoding the human UGT1A1 transgene (rAAV8-hUGT1A1)
- rabbit
- rabbit anti-humanT-lymphocyte immunoglobulin
- rabbit anti-human thymocyte
- rabbit anti-human thymocyte immunoglobulin
- rabbit haemorrhagic disease vaccine (inactivated)
- rabbit haemorrhagic disease vaccine (inactivated, recombinant)
- rabbit haemorrhagic disease virus, capsid protein antigen, recombinant
- rabbit hemorrhagic disease virus 2 VP1AB
- rabbit hemorrhagic disease virus VP1A
- rabeprazole
- rabeprazole (sodium)
- rabies recombinant canarypox virus (vCP65)
- rabies vaccine
- rabies vaccine (live, oral) for foxes and raccoon dogs
- racecadotril
- rADAMTS13
- radiprodil
- radium (223Ra) dichloride
- radium Ra223 dichloride
- rafoxanide
- Ragweed pollen extract (Ambrosia artemisiifolia)
- ralinepag
- ralmitaront
- raloxifene
- raloxifene hydrochloride
- raltegravir
- raltegravir potassium
- raltitrexed
- raludotatug deruxtecan
- ramipril
- ramucirumab
- ranibizumab (5)
- ranitidine
- ranolazine
- rapibloc
- raploc
- rasagiline
- rasagiline tartrate
- rasburicase
- ravagalimab
- ravulizumab
- raxibacumab
- raxtozinameran
- reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain
- reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
- rebisufligene etisparvovec
- reboxetine
- recombinant 10 kD culture filtrate protein
- recombinant adeno-associated viral (rAAV) vector expressing the human ornithine transcarbamylase (hOTC) gene
- recombinant adeno-associated virus Olig001 containing human aspartoacylase cDNA
- recombinant adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain
- recombinant anti-human CD20 and anti-human CD3 monoclonal antibody (RO7082859; CD20 CD3 TCB)
- recombinant Bet v1 folding variant (rBet v1-FV)
- recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2a open reading frame 2 protein, inactivated,Recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2b open reading frame 2 protein, inactivated
- recombinant cholera toxin B subunit
- recombinant Clostridioides difficile toxoid A
- recombinant Clostridioides difficile toxoid B
- recombinant COVID-19 subunit nanoparticle (adjuvanted with AS03) (GBP510)
- recombinant dimer of 6 kD early secretory antigenic target
- recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live
- recombinant fusion protein linking iduronate 2-sulfatase to engineered Fc with binding site for transferrin receptor (DNL310)
- recombinant hepatitis B vaccine
- recombinant human acid ceramidase (RVT-801)
- recombinant human A disintegrin and metalloprotease with thrombospind type-1 motifs 13
- recombinant human albumin fusion protein
- recombinant human anti-Rhesus D monoclonal antibody (LFB-R593)
- recombinant human antibody against activin type IIB receptors
- recombinant human antibody against the respiratory syncytial virus fusion protein (REGN2222)
- recombinant human beta-glucuronidase (rhGUS, UX003)
- recombinant human C1 inhibitor
- recombinant human C1-inhibitor
- recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1
- recombinant human epidermal growth factor
- recombinant human glutamic acid decarboxylase (rhGAD65)
- recombinant human granulocyte colony-stimulating factor – human immunoglobulin Fc fusion protein (rhG-CSF-Fc)
- recombinant human granulocyte colony stimulating factor
- recombinant human granulocyte colony stimulating factor coupled with recombinant human albumin fusion protein
- recombinant human growth hormone fused to hybrid Fc composed of the hinge region and N-terminal of CH2 domain of IgD and C-terminal of CH2 and full CH3 domain of IgG4
- recombinant human growth hormone modified by fusion with two hydrophilic polypeptide chains (VRS-317)
- recombinant human heparan-N-sulfatase
- recombinant human IgGlA monoclonal Fab antibody
- recombinant human interferon alfa-2a (1)
- recombinant humanised monoclonal antibody (IgG1, Kappa) to IL-5
- recombinant humanised monoclonal immunoglobulin G4, with specificity for human tau (UCB0107)
- recombinant humanized anti-alpha-synuclein IgG1 monoclonal antibody
- recombinant humanized anti-blood dendritic cell antigen 2 (BDCA2) monoclonal antibody (BIIB059)
- recombinant humanized anti-MMP9 monoclonal antibody IgG4 (GS-5745)
- recombinant humanized IgG1, kappa light chain, long-acting monoclonal antibody (STAR-0215)
- recombinant humanized monoclonal antibody (immunoglobulin gamma-1 with kappa light chains, IgG1κ) directed against integrin αvβ8 produced in Chinese Hamster Ovary (CHO) cells
- recombinant human lecithin cholesterol acyltransferase
- recombinant human monoclonal antibody against growth differentiation factor 8 (REGN1033)
- recombinant human monoclonal antibody of the IgG1 class to insulin-like growth factor-1 receptor (RO4858696)
- recombinant human monoclonal antibody to GM-CSF (GSK3196165)
- recombinant human monoclonal antibody to hsp
- recombinant human monoclonal antibody to human interleukin 17A (AIN457)
- recombinant human monoclonal antibody to the p40 subunit of human interleukin-12 and human interleukin-23 of the IgG1-class (ABT-874)
- recombinant human monoclonal IgG1 antibody directed against Programmed Death Ligand-1 (anti-PD-L1) (MSB0010718C)
- recombinant human n-acetylgalactosamine-6-sulfatase
- recombinant human N-acetylgalactosamine-6-sulfatase (elosulfase alfa)
- recombinant human N-acetylglucosaminidase
- recombinant human nerve growth factor
- recombinant human progranulin fused to an Fc fragment engineered to contain a human transferrin receptor 1 binding domain (DNL593)
- recombinant human tissue nonspecific alkaline phosphatase (TNSALP) fragment crystallizable (Fc) deca aspartate fusion protein (ALXN1850)
- recombinant inactivated avian influenza virus
- recombinant Influenza Hemagglutinin-strain A (H1N1 subtype)
- recombinant Influenza Hemagglutinin-strain A (H3N2 subtype)
- recombinant influenza hemagglutinin-strain B (RIV3)
- recombinant Influenza Hemagglutinin-strain B (Victoria lineage)
- recombinant Influenza Hemagglutinin-strain B (Yamagata lineage) (RIV4)
- recombinant L-asparaginase
- recombinant modified human growth hormone
- recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP); Ebola virus Sudan Gulu strain GP; Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP
- recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8 (AK002)
- recombinant Neisseria meningitidis group B fHbp 2-3-1.13NB fusion protein
- recombinant Neisseria meningitidis group B fHbp fusion protein
- recombinant Neisseria meningitidis group B NadA protein
- recombinant Neisseria meningitidis group B NHBA fusion protein
- recombinant Neisseria meningitidis serogroup B protein 1
- recombinant Neisseria meningitidis serogroup B protein 2
- recombinant Neisseria meningitidis serogroup B protein 3
- recombinant neisseria meningitis group B Protein 287-953
- recombinant neisseria meningitis group B Protein 936-741
- recombinant Neisseria meningitis group B Protein 961c
- recombinant neisseria meningitis group B Protein 961c (MenACWY-7B vaccine)
- recombinant omega interferon of feline origin
- recombinant parathyroid hormone
- recombinant porcine factor VIII, B-domain deleted
- recombinant protein Q from Leishmania infantum MON-1
- recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E
- recombinant respiratory syncytial virus vaccine
- recombinant rusion protein linking coagulation Factor VIIa with Albumin (rVIIa-FP; CSL689)
- recombinant salmon calcitonin
- recombinant SARS CoV2 spike protein
- recombinant Streptococcus equi protein CCE
- recombinant Streptococcus equi protein Eq85
- recombinant Streptococcus equi protein IdeE
- recombinant turkey herpesvirus, strain vhvt013-69, live
- recombinant type-D Pasteurella-multocida toxin
- recombinant varicella zoster virus glycoprotein E
- recombinant varicella zoster virus glycoprotein E adjuvanted (CRV-101)
- recombinant Verotoxin 2e of E. coli
- recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein
- regadenoson
- regdanvimab
- regorafenib
- relamorelin
- relatlimab
- reldesemtiv
- relebactam
- relebactam (MK-7655A)
- relebactam monohydrate
- relfovetmab
- relugolix
- remdesivir
- rememulgene arelactibac
- remibrutinib
- remimazolam
- remimazolam besilate
- repagermanium
- repaglinide
- reparixin
- repotrectinib
- reslizumab
- resmetirom
- resminostat
- resminostat mesilate
- resocortol butyrate
- respiratory syncytial virus (RSV) PreF3 recombinant fusion protein/AS01 (RSVPreF3 OA)
- respiratory Syncytial Virus, subgroup A, stabilized prefusion F protein 847A
- respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B
- Respiratory syncytial virus mRNA vaccine (nucleoside modified)
- Respiratory Syncytial Virus PreF3 recombinant fusion protein (RSVPreF3)
- Respiratory Syncytial Virus recombinant glycoprotein F stabilised in the pre-fusion conformation (RSVPreF3) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology
- Respiratory Syncytial Virus stabilised prefusion F subunit vaccine
- Respiratory Syncytial Virus stabilised prefusion f subunit vaccine (RSVpreF)
- respiratory syncytial virus vaccine (bivalent, recombinant)
- retapamulin
- retatrutide
- reteplase
- retifanlimab
- retigabine
- retinol
- retinyl palmitate
- retosiban
- reviparin
- revusiran
- rezafungin
- rezafungin acetate
- rhPSMA-7.3 (18F)
- ribavirin
- ribitol
- ribociclib
- ribociclib succinate
- ridinilazole (hydrate)
- rifampicin
- rifamycin
- rifamyciun
- riletamotide
- rilmenidine
- rilonacept
- rilpivirine
- rilpivirine hydrochloride
- riluzole
- rilvegostomig
- rilzabrutinib
- rimegepant
- rimexolone
- rimiducid
- rimonabant
- riociguat
- ripasudil
- ripretinib
- risankizumab
- risdiplam
- risedronate
- risedronate sodium
- risedronic acid
- risperidone
- ritlecitinib
- ritlecitinib tosilate
- ritodrine
- ritonavir
- rituximab (8)
- rivaroxaban
- rivastigmine
- rivastigmine hydrogen tartrate
- rivoceranib
- rivoceranib (mesilate)
- rivogenlecleucel
- rizatriptan
- rizatriptan benzoate
- robenacoxib
- rocatinlimab
- rocuronium
- rofecoxib
- roflumilast
- rogaratinib
- rolapitant
- rolofylline
- romidepsin
- romifidine
- romiplostim
- romosozumab
- ropeginterferon alfa-2b
- ropinirole
- ropinirole hydrochloride
- ropivacaine
- rosiglitazone
- rosiglitazone maleate
- rosuvastatin
- rosuvastatin calcium
- rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant
- rotavirus serotype G1
- rotavirus serotype G2
- rotavirus serotype G3
- rotavirus serotype G4
- rotavirus serotype P1
- rotavirus serotype P1A[8]
- rotavirus vaccine
- rotavirus vaccine, live
- rotigotine
- rovalpituzumab tesirine
- roxadustat
- roxithromycin
- rozanolixizumab
- rozibafusp alfa
- RSV preF protein
- RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)]
- rubella vaccine
- rubella virus Wistar RA 27/3 strain (live, attenuated)
- rubidium (82Rb)
- rubidium (82Rb) chloride
- rubitecan
- ruboxistaurin
- rucaparib
- Rucaparib camsylate
- rufinamide
- rufloxacin
- runrapiq
- rupatadine
- rupatadine fumarate
- rurioctocog alfa pegol
- rusfertide
- ruxolitinib
- ruxolitinib (phosphate)
- ruxolitinib phosphate
- ruzotolimod
- rye pollen
- sabatolimab
- saccharomyces boulardii
- sacituzumab govitecan
- sacubitril
- safinamide
- safinamide methanesulfonate
- salbutamol
- salbutamol sulfate
- salicylic acid
- salmeterol
- salmeterol xinafoate
- Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 038-90, inactivated; Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 076-94, inactivated; and Salmonella enterica, subsp. enterica, serovar Infantis, strain SM-595, inactivated
- Salmonella enteritidis, Salmonella typhimurium and Salmonella infantis vaccine (inactivated) for chickens
- salmon pancreas disease vaccine (recombinant DNA plasmid)
- samarium (153Sm) lexidronam pentasodium
- samarium [153Sm] lexidronam pentasodium
- sapropterin
- sapropterin dihydrochloride
- saquinavir
- sargramostim
- sarilumab
- sarizotan hydrochloride
- sarolaner
- SARS-CoV-2 (Omicron XBB.1.5) recombinant spike protein
- SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain)
- SARS-CoV-2 virus, beta-propiolactone inactivated adjuvanted with CpG 1018 (VLA2001)
- SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion dimer produced by recombinant DNA technology
- SARS-CoV-2 virus recombinant spike protein receptor binding domain fusion heterodimer (B.1.351 and B.1.1.7 strains) (beta-alpha variants)
- SARS-CoV-2 virus recombinant spike protein receptor binding domain fusion homodimer - XBB.1.16-XBB.1.16 variant
- SARS-CoV2 prefusion Spike delta TM (CoV-2 preS dTM) adjuvanted with AS03
- SARS CoV-2 (Original) recombinant spike protein
- sasanlimab
- satavaptan
- satoreotide trizoxetan
- satralizumab
- satraplatin
- savolitinib
- saxagliptin
- saxagliptin hydrochloride
- scopolamine
- sebelipase alfa
- sebetralstat
- secale cereale
- secretin
- secukinumab
- seladelpar
- seladelpar lysine dihydrate
- selamectin
- selatogrel
- selepressin
- selexipag
- selinexor
- selonsertib
- selpercatinib
- seltorexant
- selumetinib
- selumetinib sulfate
- semaglutide
- semuloparin sodium
- senaparib
- sepiapterin
- sepofarsen
- SER-109 (Eubacterial Spores, Purified Suspension, Encapsulated)
- seralutinib
- serelaxin
- serine
- serlopitant
- serotype 26 adenovirus encoding mosaic 1 HIV-1 envelope protein (Ad26.Mos1.Env)
- serotype 26 adenovirus encoding mosaic 1 HIV-1 group-specific antigen and polymerase proteins (Ad26.Mos1.Gag-Pol)
- serotype 26 adenovirus encoding mosaic 2 HIV-1 group-specific antigen and polymerase proteins (Ad26.Mos2.Gag-Pol)
- serotype 26 adenovirus encoding mosaic 2S HIV-1 envelope protein (Ad26.Mos2S.Env) [Ad26.Mos4.HIV]
- serplulimab
- sertindole
- sertraline
- setanaxib
- setmelanotide
- setrusumab
- sevasemten
- sevelamer
- sevelamer carbonate
- sevelamer hydrochloride
- severe acute respiratory syndrome coronavirus 2 recombinant spike protein nanoparticle vaccine/ matrix-M1 adjuvant (NVX-CoV2373)
- sevoflurane
- shingles (herpes zoster) vaccine (live)
- sialic acid
- sibeprenlimab
- sibutramine
- sildenafil
- sildenafil citrate
- silodosin
- siltuximab
- silver sulfadiazine
- silybum marianum (L.) gaertn., fructus
- simeprevir
- simethicone
- simeticone
- simoctocog alfa
- simtuzumab
- simvastatin
- sinapultide
- single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
- single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
- single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A/H1N1, A/H3N2, and B/Victoria and the N-terminal domain (NTD) and receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein (mRNA-1083)
- single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A and B (mRNA-1010)
- single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation (mRNA-1345)
- single chain urokinase plasminogen activator (scuPA)
- single strain of non-genetically modified Prevotella histicola (EDP1815)
- sintilimab
- sipavibart
- siponimod
- siponimod (hemifumarate)
- siponimod fumaric acid
- sirolimus
- sirukumab
- sitagliptin
- sitagliptin (hydrochloride monohydrate)
- sitagliptin fumarate
- sitagliptin hydrochloride
- sitagliptin hydrochloride monohydrate
- sitagliptin phosphate monohydrate
- sitaxentan sodium
- sitravatinib (malate)
- sivopixant
- skeletal-muscle-derived cells
- skimmed cow's milk powder
- small interfering RNA targeting human TRPV1 mRNA
- smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara)
- sodium ({(2S)-1,4-bis[2-(4-chloro-3-fluorophenoxy)acetamido]bicyclo[2.2.2]octan-2-yl}oxy)methyl hydrogen phosphate-2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1/1)
- sodium 2,2-dimethylbutyrate (HST5040)
- sodium acetate
- sodium acetate trihydrate
- sodium alginate oligosaccharide
- sodium ascorbate
- sodium benzoate
- sodium benzylpenilloate
- sodium carbonate
- sodium chloride
- sodium citrate
- sodium ferric gluconate
- sodium fluoride (18F)
- sodium glycerophosphate
- sodium glycerophosphate hydrated
- sodium hyaluronate
- sodium hydroxide
- sodium iodide (131I)
- sodium iron gluconate (parenteral preparations)
- sodium lactate
- sodium oxybate
- sodium phenylbutyrate
- sodium phenylbutyrate / ursodoxicoltaurine
- sodium salicylate
- sodium sulfate
- sodium sulfate (as sodium sulfate anhydrous)
- sodium sulfate anhydrous
- sodium sulphate anhydrous
- sodium tetradecyl sulfate
- sodium thiosulfate
- sodium valproate
- sodium zirconium cyclosilicate
- sofosbuvir
- solifenacin
- solifenacin (succinate)
- solithromycin
- solriamfetol
- solriamfetol hydrochloride
- soluble human T cell receptor (TCR) directed against the glycoprotein 100 (gp100) melanoma antigen, linked to the single-chain variable fragment (ScFv) domain of the anti-cluster of differentiation 3 (CD3) antibody
- soluble yeast beta-1,3/1,6-glucan
- somapacitan
- somatrogon
- somatropin (2)
- sonidegib
- sonidegib diphosphate
- sorafenib
- sorafenib tosilate
- sorbitan oleate
- sotagliflozin
- sotalol
- sotatercept
- soticlestat
- sotorasib
- sotrastaurin acetate
- sotrovimab
- sotuletinib
- soya bean oil
- soybean phospholipids (oral use)
- sparfloxacin
- sparsentan
- spartalizumab
- spectinomycin
- spesolimab
- spheroids of human autologous matrix-associated chondrocytes
- spinosad
- spiramycin
- spiramycin adipate
- spirapril
- spironolactone
- spironolactone metformin hydrochloride
- split influenza virus, inactivated (B/Victoria lineage)
- split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.
- split influenza virus, inactivated, containing antigen: A/California/7/2009 (H1N1)v like strain (X-179A)
- split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
- split influenza virus, inactivated containing antigen equivalent to A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-179A)), adjuvanted
- split influenza virus, inactivated containing antigen equivalent to A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-179A)), non-adjuvanted
- split influenza virus, inactivated containing antigens equivalent to the A/H1N1-like strain
- split influenza virus, inactivated containing antigens equivalent to the A/H1N1-like strain/Split influenza virus, inactivated containing antigens equivalent to the A/H3N2-like strain/Split influenza virus, inactivated containing antigens equivalent to B-like strain
- split influenza virus, inactivated containing antigens equivalent to the A/H3N2-like strain
- split influenza virus, inactivated containing antigens equivalent to the B-like strain
- split influenza virus, inactivated containing antigens equivalent to the B-like strain (B/Victoria lineage)
- split influenza virus, inactivated containing antigens equivalent to the B-like strain (B/Yamagata lineage)
- split influenza virus, inactivated containing antigens equivalent to the B-like strain (Victoria lineage)
- split influenza virus, inactivated containing antigens equivalent to the B-like strain (Yamagata lineage)
- split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A
- staphylococcus aureus
- staphylococcus aureus (CP8) strain SP 140 inactivated, expressing slime-associated antigenic complex
- stavudine
- sterculia
- sterculia, frangula
- stiripentol
- streptococcus aga
- Streptococcus equi vaccine (recombinant proteins)
- streptococcus mitis
- streptococcus pneumoniae
- streptococcus pyogenes
- Streptococcus uberis vaccine (inactivated)
- streptococcus viridans vaccine
- strontium (89sr) chloride
- strontium ranelate
- strontium succinate
- substituted 3,7-dihydro-1H-purine-2,6-dione (BI 1358894)
- sucralfate
- sucroferric oxyhydroxide
- sufentanil
- sufentanil citrate
- sugammadex
- sugammadex sodium
- sugemalimab
- sulbactam
- sulesomab
- sulfadiazine
- sulfadimethoxine
- sulfadimidine sodium
- sulfaguanidine
- sulfamethizole
- sulfamethoxazole
- sulfamethoxypyridazine
- sulfametrole
- sulfasalazine
- sulfogaiacol
- sulindac
- sulphur hexafluoride
- sulprostone
- sultamicillin
- sumatriptan
- sumatriptan succinate
- sunitinib
- sunvozertinib
- surotomycin
- surufatinib
- survodutide
- susoctocog alfa
- sutimlimab
- suvecaltamide hydrochloride
- suxamethonium
- Swine dysentery vaccine (inactivated)
- synthetic analogue of eel calcitonin
- synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues
- synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA (QPI-1002)
- synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA
- synthetic double-stranded siRNA oligonucleotide targeted against transthyretin mRNA, with six phosphorothioate linkages in the backbone, and nine 2’-fluoro and thirty-five 2’-O-methyl nucleoside residues in the sequence, which is covalently linked via a phosphodiester group to a ligand containing three N-acetylgalactosamine residues (ALN-65492)
- synthetic double-stranded small interfering RNA (siRNA) oligonucleotide specific to the mRNA of the caspase 2 gene
- synthetic hypericin
- synthetic peptide analogue of GnRF conjugated to diptheria toxoid
- synthetic ribonucleic acid oligonucleotide directed against superoxide dismutase 1 messenger ribonucleic acid (tofersen)
- synthetic surfactant protein B analogue (CHF 5633)
- synthetic surfactant protein C analogue
- T-cell bispecific antibody targeting carcinoembryonic antigen expressed on tumor cells and CD3 epsilon chain present on T-cells
- T-lymphocytes enriched leukocyte preparation depleted ex vivo of host host-alloreactive T cells using photodynamic treatment (ATIR101)
- tabalumab
- tabelecleucel
- tacrolimus
- tacrolimus monohydrate
- tadalafil
- tafamidis
- tafamidis meglumine
- tafasitamab
- tafluprost
- tagraxofusp
- talazoparib
- taldefgrobep alfa
- taliglucerase alfa
- talimogene laherparepvec
- talquetamab
- tamoxifen
- tamsulosin
- tamsulosine
- tamsulosin hydrochloride
- tanezumab
- taniborbactam
- tanimilast
- tapderimotide
- tapentadol
- tapentadol hydrochloride
- taranabant
- tarlatamab
- tartaric acid
- tarumase
- tasimelteon
- tasipimidine
- tasonermin
- taspoglutide
- taurine
- tauroselcholic (75Se) acid
- tauroursodeoxycholic acid
- tavapadon
- tazarotene
- tazemetostat
- tazobactam
- tazobactam sodium
- tebentafusp
- technetium (99mTc) bicisate
- technetium (99mTc) exametazime
- technetium (99mTc) hynic-octeotide
- technetium (99mtc) mebrofenin
- technetium (99mTc) pertechnetate
- technetium (99mTc) sestamibi
- technetium (99mTc) tetrofosmin
- technetium (99mTc) trofolastat chloride
- teclistamab
- tecovirimat
- tecovirimat monohydrate
- tedizolid phosphate
- teduglutide
- tegafur
- tegaserod
- tegomil fumarate
- teicoplanin
- telaprevir
- telavancin
- telavancin hydrochloride
- telbivudine
- telcagepant
- telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy- 8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2- b]quinolin-14-yl]bicyclo[1.1.1]pentan-1-yl}amino)-1-oxopropan-2-yl]-3-methylbutanamide
- telisotuzumab vedotin
- telitacicept
- telithromycin
- telmisartan
- telotristat ethyl
- telotristat etiprate
- temelimab
- temoporfin
- temozolomide
- temsirolimus
- tenecteplase
- tenofovir alafenamide
- tenofovir alafenamide fumarate
- tenofovir disoproxil
- tenofovir disoproxil fumarate
- tenofovir disoproxil maleate
- tenofovir disoproxil phosphate
- tenofovir disoproxil succinate
- tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells
- tenonitrozole
- tenoxicam
- teplizumab
- tepotinib
- tepotinib hydrochloride monohydrate
- tepoxalin
- teprotumumab
- terazosin
- terbinafine
- terbinafine hydrochloride
- terbutaline
- terfenadine
- terguride (hydrogenmaleate)
- teriflunomide
- teriparatide (9)
- terlipressin
- terpine
- terpineol
- tesamorelin
- testosterone
- testosterone undecanoate
- testosterone undecylat
- tetanus
- tetanus protein
- tetanus toxoid
- tetanus toxoid adsorbed on aluminium hydroxide, hydrated
- tetanus vaccine
- tetrabenazine
- tetrabenazine (ADV6979)
- tetracaine
- tetracaine hydrochloride
- tetracycline
- tetracycline hydrochloride
- tetrahydrouridine
- tetrazepam
- tetrofosmin
- tetryzoline
- tezacaftor
- tezepelumab
- TGp1PTH1-34 L-Asparaginyl-L-glutaminyl-L-glutamyl-L-glutaminyl-L-valy1-L-seryl-L-prolyl-L-leucyl-L-tyrosyl-L-lysil-L-asparaginyl-L-arginyl-L-seryl-L-valyl-L-seryl-L-glutamyl-L-isoleucyl-L-glutaminyl-Lleucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucyl-L-glycyl-L-lysyl-L-histidyl-L-leucyl-Lasparaginyl-L-seryl-L-methionyl-L-glutamyl-L-arginyl-L-valyl-L-glutamyl-L-tryptophanyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutamyl-L-asparty-L-valyl-L-histidyl-L-asparaginyl-Lphenylalanine-, acetate salt
- thalidomide
- thallium [201TL]
- Theobroma cacao L.
- theophylline
- therapeutic DNA plasmid vaccine targeting HPV16 E6 and E7 proteins (VB10.16)
- the whole range of unmanipulated autologous mononuclear cells derived from human umbilical cord blood (Hau-UCB-mnc)
- thiamazole
- thiamine
- thiamine hydrochloride
- thiamine nitrate
- thiamphenicol
- thienopyrimidine derivative
- thiocolchicoside
- thiopental
- thiotepa
- threonine
- thrombin
- thrombin, aprotinin
- thrombin alfa
- thrombomodulin alfa
- thyrotropin alfa
- tiagabine
- tiamulin hydrogen fumarate
- tianeptine
- tiapride
- tibolone
- ticagrelor
- tick-borne encephalitis vaccine (inactivated)
- ticlopidine
- tifacogin
- tifcemalimab
- tigecycline
- tigilanol tiglate
- tigolaner
- tigulixostat
- tildacerfont
- tildipirosin
- tildrakizumab
- tilmanocept
- tilmicosin
- tilsotolimod
- tiludronic acid
- timolol
- timolol (systemic use)
- timolol maleate
- timrepigene emparvovec
- tinengotinib
- tinlarebant
- tioconazole
- tiotropium
- tiotropium bromide (monohydrate)
- tipifarnib
- tipiracil
- tipiracil hydrochloride
- tipranavir
- tiprelestat
- tiragolumab
- tirasemtiv
- tiratricol
- tirbanibulin
- tirofiban
- tirzepatide
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- titanium dioxide
- tivantinib
- tivozanib
- tivozanib hydrochloride monohydrate
- tixagevimab
- tixocortol
- tixocortol pivalate
- tizanidine
- tobramycin
- toceranib
- tocilizumab (3)
- tocofersolan
- tocopherol
- tofacitinib
- tofacitinib citrate
- tofersen
- tofisopam
- tolcapone
- tolfenamic acid
- tolonium chloride
- tolperisone
- tolperisone hydrochloride
- tolterodine
- toltrazuril
- tolvaptan
- tominersen
- topiramate
- topotecan
- topotecan hydrochloride
- torasemide
- torasemide anhydrous
- toremifene
- toripalimab
- tovorafenib
- tozinameran
- tozorakimab
- trabectedin
- tralokinumab
- tramadol
- tramadol hydrochloride
- trametinib
- trametinib dimethyl sulfoxide
- trandolapril
- tranexamic acid
- transglutaminase 2 inhibitor
- trastuzumab (10)
- trastuzumab-exatecan derivative antibody-drug conjugate
- trastuzumab deruxtecan
- trastuzumab duocarmazine
- trastuzumab emtansine
- travoprost
- trazodone
- trazodone (hydrochloride)
- tremelimumab
- trenonacog alfa
- treosulfan
- treprostinil
- treprostinil (palmitil)
- treprostinil diethanolamine
- treprostinil diolamine
- treprostinil sodium
- tretinoin
- triacetonamine tosilate
- triamcinolone
- triamcinolone acetonide
- triamterene
- triazolam
- triclabendazole
- trientine
- trientine dihydrochloride
- trientine tetrahydrochloride
- trifarotene
- trifluridine
- triglyceride combinations
- triglycerides medium-chain
- trilaciclib (dihydrochloride)
- trilostane
- trimegestone
- trimeric, recombinant HIV-1 envelope glycoprotein 140 of Clade C, adjuvanted with aluminium phosphate [Clade C gp140]
- trimeric, recombinant HIV-1 envelope glycoprotein 140 of Clade C / trimeric, recombinant HIV-1 envelope glycoprotein 140 containing motifs of multiple HIV-1 variants, adjuvanted with aluminium phosphate [Clade C gp140/ Mosaic gp140]
- trimetazidine
- trimetazidine (dihydrochloride)
- trimetazidine dihydrochloride
- trimetazidine hydrochloride
- trimethoprim
- trimethylphloroglucinol
- trimodulin
- trimodulin (human IgM, IgA, IgG solution)
- triprolidine
- triprolidine hydrochloride
- triptorelin
- triptorelin acetate
- tris(hydroxymethyl)aminomethane trihydrate (PF-05221304-82)
- trivalent, seasonal, recombinant influenza hemagglutinin vaccine
- trofinetide
- tropicamide
- tropifexor
- troriluzole
- troriluzole hydrochloride
- troriluzole hydrochloride monohydrate
- trovafloxacin
- tryptophan
- tuberculin purified protein derivative
- tucatinib
- tulathromycin
- tulobuterol
- turkey herpes virus, expressing infectious bursal disease virus and avian infectious laryngotracheitis virus, strain HVT/IBD/ILT, live
- turkey herpes virus, strain FC-126, expressing infectious bursal disease virus VP2 protein, live
- turkey herpesvirus, strain FC126, Live
- turkey herpes virus, strain HVT-IBD, expressing infectious bursal disease virus VP2 protein, live
- turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV, live recombinant
- turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5
- Turkey herpesvirus, strain rHVT-IBD-H5 (cell-associated), expressing the VP2 protein gene of Infectious bursal disease virus and haemagglutinin gene of Avian influenza virus subtype H5, live
- turkey herpesvirus, strain rHVT/AI-H5 (cell-associated), expressing haemagglutinin gene of Avian influenza subtype H5, Live
- turkey herpes virus, strain rHVT/ND/IBD, expressing the fusion protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus, live recombinant
- turkey herpes virus, strain rHVT/ND expressing Newcastle disease virus, live
- turkey herpesvirus strain HVT/ND/IBD/ILT (cell-associated), expressing the fusion protein gene of Newcastle disease virus, the VP2 protein gene of infectious bursal disease virus and the glycoproteins gD and gI genes of infectious laryngotracheitis virus, live
- turkey rhinotracheitis virus
- turkey rhinotracheitis virus (inactivated)
- turkey rhinotracheitis virus, strain 1062, live
- turoctocog alfa
- turoctocog alfa pegol
- turoctocog alpha
- turpentine (essence oil)
- turpentine oil
- tylosin
- tylosin tartrate
- tylvalosin
- type A (H1N1) strain; type A (H3N2) strain; type B strain
- typhoid polysaccharide vaccine
- typhoid vaccine
- tyrosine
- ublituximab
- ulimorelin
- ulipristal
- ulipristal acetate
- ulviprubart
- umbralisib tosylate
- umeclidinium
- umeclidinium bromide
- upadacitinib
- upadacitinib (ABT-494)
- upifitamab rilsodotin
- uproleselan
- urapidil
- urea
- urea (13C)
- urea hydrogen peroxide
- urofollitropin
- urokinase
- ursodeoxycholic acid
- ursodoxicoltaurine
- ustekinumab (14)
- utreloxastat
- vaborbactam
- vaccine against babesiosis in dogs
- vaccine against coccidiosis in chickens
- vaccine against equine influenza and tetanus in horses
- vaccine against equine influenza in horses
- vaccine against feline leukaemia
- vaccine against feline viral rhinotracheitis, calicivirosis, panleucopenia and leukaemia in cats
- vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections
- vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections
- vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia
- vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections
- vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia
- vaccine against feline viral rhinotracheitis and feline calicivirosis
- vaccine to aid in prevention of West Nile virus
- vaccine to provide passive immunity to the progeny against E. coli in pigs
- vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs
- vadadustat
- valaciclovir
- valaciclovir (hydrochloride)
- valdecoxib
- valemetostat tosilate
- valganciclovir
- valine
- valine L
- valnemulin
- valoctocogene roxaparvovec
- valpriomide
- valproate
- valproate bismuth
- valproate magnesium
- valproate pivoxil
- valproate semisodium
- valproic acid
- valpromide
- valsartan
- vamikibart
- vamorolone
- vancomycin
- vandetanib
- vanzacaftor calcium dihydrate
- vardenafil
- varenicline
- varicella-zoster immunoglobuline
- varicella-zoster virus (inactivated)
- varicella-zoster virus (live, attenuated)
- varicella vaccine (live)
- varicella virus OKA strain (live, attenuated)
- varicella zoster-immunoglobulin
- vatinoxan hydrochloride
- vatiquinone
- vatreptacog alfa (activated)
- vCP65 virus
- Vcp 2242 virus / Vcp1529 virus / Vcp1533 virus / vCP3011 virus
- vecuronium bromide
- vedaprofen
- vedolizumab
- velagliflozin
- velagliflozin L-proline monohydrate
- velaglucerase alfa
- veliparib
- velmanase alfa
- velpatasvir
- vemurafenib
- venetoclax
- venglustat
- venlafaxine
- vepsitamab
- veralipride
- verapamil
- verdiperstat
- vericiguat
- verinurad
- vernakalant hydrochloride
- verteporfin
- vesleteplirsen
- Vespula SPP. (802)
- vestronidase alfa
- vibegron
- vibosameran (BNT111)
- vibostolimab
- vibrio cholerae, strain cvd 103-hgr, live
- vibrio cholerae 01
- vicriviroc maleate
- vigabatrin
- vilanterol
- vilanterol trifenatate
- vildagliptin
- vilobelimab
- viltolarsen
- vimseltinib
- vimseltinib dihydrate
- vincristine
- vindesine
- vinflunine
- vinorelbine
- virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella
- virus-like particle of SARS-CoV-2 spike protein (recombinant, adjuvant) (CoVLP)
- vismodegib
- vitamin A (retinol and its esters)
- vitamin D3
- vixarelimab
- voclosporin
- volanesorsen
- volanesorsen sodium
- volasertib
- volixibat potassium
- volrustomig
- vonapanitase
- vonicog alfa
- vonoprazan
- von Willebrand factor
- vorapaxar
- vorapaxar sulfate
- vorasidenib
- vorasidenib hemicitrate hemihydrate
- voretigene neparvovec
- voriconazole
- vorinostat
- vortioxetine
- vosaroxin
- vosoritide
- votumumab
- voxelotor
- voxilaprevi
- vupanorse
- vutrisiran
- vutrisiran sodium
- warfarin
- wasp venom
- West Nile fever vaccine (live recombinant)
- West Nile recombinant canarypox virus (vCP2017 virus)
- whole-cell heat-inactivated bacterial strains of Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Enterococcus faecalis
- whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs
- whole virion influenza vaccine, inactivated containing antigen of strain A/California/07/2009 (H1N1)v
- wild thyme
- xalnesiran
- XEN1101
- xevinapant
- ximelagatran
- xipamide
- xylazine
- xylitol
- xylometazoline
- xylometazoline hydrochloride
- yellow fever vaccine (live)
- Yellow fever virus, strain vYF-247
- yohimbine
- yttrium (90Y) chloride
- yttrium [90Y] chloride
- zafirlukast
- zaleplon
- zamtocabtagene autoleucel
- zanamivir
- zandelisib
- zanidatamab
- zanubrutinib
- zanzalintinib
- zapomeran
- zasocitinib
- zenocutuzumab
- zibotentan
- ziconotide
- zidebactam
- zidesamtinib
- zidovudine
- zigakibart
- zilebesiran (sodium)
- zilovertamab vedotin
- ziltivekimab
- zilucoplan
- zimberelimab
- zinc
- zinc gluconate
- zinc oxide
- zinc sulfate
- zipalertinib
- ziprasidone
- zirconium (89Zr) girentuximab senvedoxam
- zofenopril
- zolbetuximab
- zoledronic acid
- zoledronic acid monohydrate
- zoliflodacin
- zolmitriptan
- zolpidem
- zolpidem (tartrate)
- zongertinib
- zonisamide
- zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
- zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted)
- zorecimeran
- zuclopenthixol
- zuranolone
- zuretinol (acetate)
- [(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl) propoxy] biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid hydrate (TAK-875)
- [18F]CTT1057
- [N-((2S,3R,3aS,3´R,4a´R,6S,6a´R,6b´S,7aR,12a´S,12b´S,Z)-3,6,11´,12b´-tetramethyl-2´,3a,3´,4,4´,4a´,5,5´,6,6´,6a´,6b´,7,7a,7´,8´,10´,12´,12a´,12b´-icosahydro-1´H,3Hspiro[furo[3,2-b]pyridine-2,9´-naphtho[2,1-a]azulene]-3´-yl)methanesulfonamide hydrochloride]
- ±3,4-methylenedioxymethamphetamine hydrochloride (MDMA)
- Agenda
- Annex to CHMP highlights
- Annual Report
- Application withdrawal assessment report
- Committee meeting report
- COVID-19 vaccine safety update
- Direct healthcare professional communication
- EPAR - All authorised presentations
- EPAR - Amended Product Information
- EPAR - Assessment report - Variation
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation
- EPAR - Conditions imposed on member states for safe and effective use
- EPAR - Overview
- EPAR - Paediatric investigation plan compliance statement
- EPAR - Procedural steps taken and scientific information after authorisation
- EPAR - Procedural steps taken before authorisation
- EPAR - Product Information
- EPAR - Product Information tracked changes
- EPAR - Public assessment report
- EPAR - Risk-management-plan summary
- EPAR - Risk management plan
- EPAR - Scientific conclusion
- EPAR - Scientific Discussion
- EPAR - Scientific Discussion - Variation
- EPAR - Steps taken after authorisation when a cutoff date has been used
- Herbal - Call for data
- Herbal - Herbal monograph
- Herbal - HMPC assessment report
- Herbal - HMPC opinion on a European Union herbal monograph
- Herbal - List of references supporting the assessment report
- Herbal - Overview of comments received during consultation
- Herbal - Summary of assessment report for the public
- Herbal – European Union herbal monograph
- Herbal – European Union list entry
- Leaflet
- Maximum Residue Limits - Divergent opinion
- Maximum Residue Limits - Opinion
- Maximum Residue Limits - Report
- Maximum Residue Limits - Summary of opinion
- Medicine QA
- Medicines under additional monitoring
- Minutes
- Newsletter
- Opinion on any scientific matter
- Opinion outside EU - All Authorised presentations
- Opinion outside EU - All presentations
- Opinion outside EU - Assessment report - Variation
- Opinion outside EU - Medicine questions and answers
- Opinion outside EU - Procedural steps taken and scientific information after opinion
- Opinion outside EU - Procedural steps taken before opinion
- Opinion outside EU - Product information
- Opinion outside EU - Public assessment report
- Opinion outside EU - Risk-management-plan summary
- Opinion outside EU - Scientific discussion
- Opinion outside EU - Summary for the public
- Opinion outside EU - Summary of opinion
- Opinion outside EU - Summary of opinion - Initial authorisation
- Opinion outside EU - Withdrawal assessment report
- Orphan designation
- Orphan review
- Other
- Overview of comments
- Periodic safety update single assessment
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision
- PIP - Paediatric-investigation-plan summary
- PIP decision
- Position statement
- PRAC recommendation on signal
- Presentation
- Press Release
- Procurement
- Public Statement
- Recommendation on medication errors
- Recruitment
- Referrals document
- Regulatory and procedural guideline
- Report
- Scientific guideline
- Standard Operating Procedure - SOP
- Summary of opinion
- Summary of opinion - Initial authorisation
- Template or form
- Withdrawal letter
- Work Instruction - WIN
- Work programme
- Advanced therapies
- Antimicrobial resistance
- Biologicals (5)
- Biosimilars (160)
- Brexit
- Careers
- Clinical trials
- Compassionate use
- Compliance and inspections
- Corporate
- COVID-19
- Data on medicines
- Early access
- Fees
- Generic and hybrid medicines
- Governance
- Innovation
- Maximum residue limit
- Medical devices
- Medication error
- Medicines (181)
- Medicines for use outside the EU
- Medicine shortages (1)
- Mpox
- Paediatrics (4)
- Parallel distribution
- Pharmacovigilance
- PRIME
- Procurement
- Product information
- Quality of medicines
- Rare diseases
- Referrals
- Regulatory and procedural guidance
- Research and development
- Scientific advice
- Scientific guidelines
- SME
- Vaccines
- Veterinary limited markets
Search results (182)
INN or common name:
ranibizumab
Therapeutic area (MeSH):
Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications
Marketing authorisation issued:
Last updated:
14 November 2025
Revision:
7
Additional monitoring
Biosimilar
Medicine
Human
Authorised
INN or common name:
ranibizumab
Therapeutic area (MeSH):
Wet Macular Degeneration; Macular Edema; Choroidal Neovascularization; Diabetes Complications
Marketing authorisation issued:
Last updated:
14 November 2025
Revision:
4
Biosimilar
Medicine
Human
Authorised
INN or common name:
insulin aspart
Therapeutic area (MeSH):
Diabetes Mellitus
Withdrawal of application:
Last updated:
14 November 2025
Medicine
Human
Application withdrawn
INN or common name:
denosumab
Therapeutic area (MeSH):
Bone Resorption
Opinion adopted:
Last updated:
14 November 2025
Biosimilar
Medicine
Human
Opinion
INN or common name:
insulin glargine
Therapeutic area (MeSH):
Diabetes Mellitus
Opinion adopted:
Last updated:
14 November 2025
Biosimilar
Medicine
Human
Opinion
INN or common name:
aflibercept
Therapeutic area (MeSH):
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Retinal Vein Occlusion; Choroidal Neovascularization
Marketing authorisation issued:
Last updated:
13 November 2025
Additional monitoring
Biosimilar
Medicine
Human
Authorised
INN or common name:
adalimumab
Therapeutic area (MeSH):
Spondylitis, Ankylosing; Hidradenitis Suppurativa; Psoriasis; Arthritis, Juvenile Rheumatoid; Uveitis
Marketing authorisation issued:
Last updated:
13 November 2025
Revision:
18
Biosimilar
Medicine
Human
Authorised
INN or common name:
adalimumab
Therapeutic area (MeSH):
Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing; Uveitis; Hidradenitis Suppurativa; Colitis, Ulcerative; Arthritis, Juvenile Rheumatoid; Crohn Disease; Skin Diseases, Papulosquamous
Marketing authorisation issued:
Last updated:
13 November 2025
Revision:
17
Biosimilar
Medicine
Human
Authorised
INN or common name:
aflibercept
Therapeutic area (MeSH):
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Retinal Vein Occlusion
Marketing authorisation issued:
Last updated:
12 November 2025
Additional monitoring
Biosimilar
Medicine
Human
Authorised
INN or common name:
ustekinumab
Therapeutic area (MeSH):
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative
Marketing authorisation issued:
Last updated:
11 November 2025
Revision:
8
Biosimilar
Medicine
Human
Authorised